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ABSTRACT 
 
 G-protein coupled receptors (GPCRs) form a superfamily of cell surface receptors with 
in excess of 2000 genes identified across taxa (Pierce et al., 2002).  They are integral membrane 
proteins that are comprised of seven hydrophobic helical segments which form a 
transmembrane spanning bundle.  Ste2p and Ste3p are Saccharomyces cerevisiae GPCRs that 
are the α-factor and a-factor pheromone receptors, respectively (Bardwell, 2005).  Ste2p in 
particular has served as an excellent model for studying the mechanisms of action of GPCRs. 
Recent results suggest that the extracellular N-terminus of the Ste2p receptor is involved in 
modulating cell wall degradation and membrane juxtaposition during yeast mating potentially 
by mediating an intercellular interaction with Ste3p (Shi et al., 2009a).   
 The goals of this project were to obtain purified mg quantities of a soluble version of a 
portion of the N-terminus of Ste2p and to acquire structural information about this region by 
performing biophysical analysis on the soluble N-terminal Ste2p fragments.  Initially, a 
synthetically produced KKK-Ste2p(14-43)-KKK peptide yielded circular dichroism (CD) 
spectra that indicated peptide secondary structure similar to what has been predicted in silico.  
Preliminary nuclear magnetic resonance (NMR) experiments with this peptide were also 
promising, yielding a correlation spectroscopy (COSY) spectrum that allowed for limited 
amino acid assignments.  A recombinant version of the N-terminus of Ste2p, including residues 
2-48 with terminal lysine residues, was expressed as a fusion protein in E. coli and the SK 
peptide was liberated by cyanogen bromide cleavage.  Dynamic light scattering (DLS) analyses 
of the SK peptide showed it was aggregated when dissolved in water, but soluble in a 
trifluoroethanolamine/water (TFE/H2O) mixture.  CD analysis of the SK peptide in TFE/H2O 
indicated that it contained more β-strand and less α-helix than the KKK-Ste2p(14-43)-KKK 
peptide.  NMR analysis was performed on both an unlabelled and 15N-labelled SK peptide, 
yielding unusable spectra with very broad bands, most likely arising from aggregation at high 
concentrations.  In conclusion, a high yield recombinant expression and purification system has 
been developed, yielding a Ste2p N-terminal peptide fragment that demonstrates some expected 
structural features.  High resolution structural information may be obtained upon further 
optimization of the solvent system. 
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1.0 LITERATURE REVIEW 
 
1.1 Introduction 
G-protein coupled receptors (GPCRs) are membrane proteins called seven 
transmembrane proteins (7 TM) (Pierce et al., 2002).  The 7 TM proteins are integral 
membrane proteins that have seven hydrophobic segments predicted to form transmembrane 
spanning helices.  The transmembrane domains are connected by intracellular and extracellular 
loops and the N-terminus is extracellular, while the C-terminus is intracellular.  These receptors 
mediate extracellular signals (proton gradients, fungal infection, light, hormones, calcium etc.) 
into intracellular responses.  In the case of the GPCRs this signalling is mediated through 
downstream G-protein activation.  Activation of the G-protein subunits leads to further 
activation of signalling cascades.  To date, a limited number of 3D structures of GPCRs have 
been resolved using either X-ray crystallography or NMR.  GPCR structural studies are 
important because GPCRs represent an important target for therapeutic drug design with 
approximately 30% of current drugs targeting GPCRs. 
The yeast, Saccharomyces cerevisiae, is an important model system for studying the 
molecular and cell biology of higher eukaryotes.  Ste2p and Ste3p are S. cerevisiae GPCRs that 
are the α-factor and a-factor pheromone receptors, respectively (Bardwell, 2005).  These 
receptors are expressed on opposite cell types and it is well documented that activation of these 
receptors by pheromones leads to G-protein mediated signalling for initiation of mating in 
yeast.  However it was also shown, using tandem affinity purification and proteoliposome 
fusion assays, that activated forms of these receptors interact with each other directly to 
promote membrane juxtaposition (Shi et al., 2007).  In vivo analysis indicated that when a yeast 
strain with the Ste2p receptor deleted, had an N-terminally truncated Ste2p receptor expressed, 
this lead to arrest prior to cell wall degradation.  In vitro characterization of this truncation 
indicated loss of the interaction between Ste2p and Ste3p as well as loss of the receptor’s ability 
to promote membrane juxtaposition.  More recently it was found that the residues Pro 15, Ile 24 
and Ile 29 in the N-terminal region of Ste2p are important in mediating mating efficiency (Shi 
et al., 2009a).  These results suggested that the N-terminus of the Ste2p receptor is involved in 
cell wall degradation and membrane juxtaposition during yeast mating potentially by mediating 
the interaction with Ste3p.  NMR analyses of the N-terminus of Ste2p would give insight into 
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the mechanisms associated with how the GPCR modulates events in later steps of mating 
including cell wall degradation and membrane fusion.  
 
1.2 G Protein Coupled Receptors (GPCRs) 
 GPCRs, also known as 7 TM receptors, are integral membrane proteins that have seven 
hydrophobic helical segments predicted to form transmembrane spanning helices (Pierce et al., 
2002).  The transmembrane domains are connected by intracellular and extracellular loops and 
the N-terminus is extracellular, while the C-terminus is intracellular.  These receptors mediate a 
wide array of extracellular signals, such as proton gradients, fungal infection, light, hormones, 
calcium, odorants, peptide pheromones, etc. into intracellular responses (Bockaert and Pin, 
1999).  The GPCR superfamily is a large and diverse family that has been found in the genomes 
of animals, plants and fungi.  In the human genome alone there are approximately 800 GPCRs 
(Bhasin and Raghava, 2004; Fredriksson et al., 2003).  The GPCRs are an important target 
family for therapeutic drug design and ~30% of all marketed prescription drugs target GPCRs 
(Jacoby et al., 2006).  
 All GPCRs have a similar secondary structure which is characterized by seven 
transmembrane spanning α-helices connected by alternating intracellular and extracellular 
loops.  However, even though they all have very similar structural features, there is no 
significant sequence similarity across the GPCR superfamily (Probst et al., 1992).  Therefore, 
classification of the GPCRs into distinct families has been complicated.  GPCRs have been 
classified using a number of different techniques, such as sequence similarity, phylogenetic 
criteria, structural and ligand binding criteria, amino acid composition, and many others 
(Bockaert and Pin, 1999; Chou and Elrod, 2002; Fredriksson et al., 2003; Kolakowski Jr., 
1994).   
 Based on sequence similarity classification, the GPCRs have been separated into six 
different families, labelled A-F (Horn et al., 2003; Kolakowski Jr., 1994).  The Class A 
receptors, or the rhodopsin-like family, is by far the largest family of GPCRs and encompasses 
~80% of all GPCRs.  This family includes receptors for biogenic amines, hormone proteins, 
odorants, peptides and lipids (Cheng et al., 2005).  This class therefore represents a very 
important group of GPCRs that are involved in many pathological conditions such as 
Parkinson’s disease, schizophrenia and other mood disorders.  Class B receptors, or the 
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Secretin-like family, is the next largest family of GPCRs.  These receptors bind large peptides 
such as secretin, glucagon, vasoactive intestinal peptide, parathyroid hormone, calcitonin and 
more (Cardoso et al., 2006).  The N-terminus of these receptors, which is important for ligand 
binding, varies from between 60-80 residues in length and contains conserved cysteine bridges 
(Fredriksson et al., 2003).  The Class C receptors, or the Metabotropic glutamate/pheromone 
family, are a smaller group of GPCRs.  This family includes metabotropic glutamate receptors, 
γ-aminobutyric acid (GABA) receptors, calcium-sensing receptors, mammalian pheromone 
receptors and taste receptors (Fredriksson et al., 2003).  The majority of the receptors in this 
family have a very large N-terminal extracellular domain and many have conserved cysteine 
residues which may be involved in ligand binding (Pin et al., 2003).  The Class D receptors 
include the fungal pheromone receptors, Ste2p and Ste3p.  This class of receptors will be 
discussed in detail in Section 1.2.  The Class E receptors, or the cyclic adenosine 
monophosphate (cAMP) receptors, are a very small group of GPCRs that are related to the 
cAMP receptors from the species, D. discoideum, also known as slime mold (Raisley et al., 
2004).  The final class of receptors are the Class F receptors or the Frizzled/Smoothened family.  
The frizzled receptors bind to specific ligands from a family of lipoglycoproteins called WNT.  
These WNT proteins bind to the cysteine-rich extracellular terminus of the frizzled receptors 
(Schulte and Bryja, 2007).  The smoothened receptors are involved in mediating signalling of 
the hedgehog pathway (Wang et al., 2009). 
 In general, GPCR signalling in the cell is accomplished through the interaction with 
heterotrimeric guanine nucleotide-binding proteins, or G-proteins.  The heterotrimer consists of 
Gα/Gβ and Gγ subunits which are membrane bound and in close proximity to the intracellular 
surface of GPCRs.  Upon activation of the GPCR, due to ligand binding, the receptor undergoes 
a conformational change which allows for interaction between the intracellular surface of the 
receptor and the G proteins (Altenbach et al., 2008; Scheerer et al., 2008).  This interaction 
results in activation of the G protein by inducing a conformational change in the G protein and 
exchanging GDP for GTP (Lambright et al., 1994).  Once the GDP is exchanged for GTP, the 
heterotrimeric G-protein dissociates from the receptor and the Gα subunit dissociates from the 
Gβγ subunit.  The Gα and Gβγ subunits go on to further activate or inhibit effector proteins, 
such as tyrosine kinases, phosphodiesterase, phosphoinositide-3-kinase, mitogen activated 
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protein kinases (MAPK), etc (Kristiansen, 2004).  The G-protein subunits stay activated until 
the GTP is hydrolyzed to GDP or inactivated by GTPase-activating proteins (GAPs). 
 
1.2.1 GPCR Structural Analysis  
 As was mentioned previously, GPCRs all contain seven hydrophobic transmembrane- 
spanning domains.  These domains are linked together by intracellular and extracellular loops.  
The N-terminal region is extracellular, while the C-terminal tail is intracellular.  Increased 
knowledge of the three-dimensional structure of GPCRs is very important for understanding 
their mechanisms of signalling and for use in designing new drugs.  Currently, the two main 
tools being used for structural analyses of GPCRs are NMR spectroscopy and X-ray 
crystallography.  X-ray crystallography uses X-rays to bombard protein crystals in order to 
determine their overall three-dimensional structure.  The first high resolution X-ray crystal 
structure of GPCRs was that of rhodopsin (Palczewski et al., 2000).  The structure was solved 
with the co-factor 11-cis-retinal, a derivative of vitamin A, which held the TM region of 
rhodopsin in the inactive state.  This was the first structure to confirm the 7 TM spanning 
helices, intradiscal and cytoplasmic loop domains as well as the conformation of the side-
chains.  Since then a number of other rhodopsin structures have emerged which have allowed 
for further refinement of the original structure (Li et al., 2004a; Okada et al., 2002; Okada et 
al., 2004; Salom et al., 2006; Teller et al., 2001).  These structures have revealed that rhodopsin 
has a β-hairpin conformation in the second intradiscal loop, which is believed to be involved in 
sheltering retinal in the closed binding pocket.  This feature has been seen in all crystal forms of 
rhodopsin but not for other GCPRs.  The original crystal structure also confirmed the disulfide 
bridge that connects the intradiscal side of transmembrane 3 (TM3) and intradiscal loop 2.  This 
is a common feature of GPCRs.  The N-terminus of Rhodopsin is 34 residues long and was 
found to contain five distorted β-strands which form a compact unit and overlays the other 
intradiscal loops.  For a number of years this was the only GPCR structure that was available.   
 The next GPCR structure that was solved was that of the human β2- adrenergic receptor 
(β2AR).  Initially, two structures were solved for β2AR, the first of which was a fusion protein 
where the third intracellular loop (IL3) was replaced with T4 lysozyme and this fusion protein 
was bound to the partial inverse agonist, carazolol (Cherezov et al., 2007).  Previous attempts to 
crystallize the wild-type β2AR were unsuccessful and this was thought to be because the IL3 
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conformation was highly flexible which would interfere in crystal-lattice formation.  Therefore, 
in the first crystal structure the IL3 was replaced with a soluble T4 lysozyme which resulted in 
the ability to produce crystals (Rosenbaum et al., 2007).  The other structure was bound to 
carazolol as well as to a antigen binding fragment (Fab) which recognizes the IL3 and provides 
conformational stability allowing for crystallization (Rasmussen et al., 2007).  Both of these 
structures were similar indicating that the addition of T4 lysozyme or the binding of Fab had 
little effect on the overall native structure.  These structures demonstrate a major difference to 
that of rhodopsin in the structure of extracellular loop 2 (EL2).  In the rhodopsin structure, 
intradiscal or EL2 forms a β-strand and closes off access to the binding pocket from the 
extracellular side, however in the β2AR structures the EL2 is partially α-helical and the binding 
pocket is left open so that it is easily accessible to ligands.  The N-terminus (residues 1-28) is 
disordered and not visible in the structure.  The next structure that was solved was that of β2AR 
again fused to T4 lysozyme, but containing a stabilizing point mutation, E122W, which was 
solved in complex with the inverse agonist timolol (Hanson et al., 2008).  This structure 
suggested a cholesterol binding pocket located between TM2, TM3 and TM4.  Then the turkey 
β1AR structure was solved, which contained multiple stabilizing mutations and was solved in 
complex with the strong antagonist cyanopindolol (Warne et al., 2008).  The human and turkey 
receptors had significant sequence similarity and it was therefore no surprise that the structures 
were very similar.  However, the major difference was in a portion of the EL2, in the turkey 
structure this region was α-helical while in the human structure it was random coil.  The N-
terminus of the turkey receptor was truncated in order to allow for purification and therefore 
information on the structure of the N-terminus was unavailable. 
 The fourth GPCR structure to be solved was that of A2A adenosine receptor in complex 
with the antagonist ZM241385 (Jaakola et al., 2008).  The adenosine structure demonstrated 
similarities to both the β2-AR and rhodopsin structures; however it also had a few differences 
such as a shifted ligand binding site.  As well, the EL2 of the adenosine receptor was 
significantly different from that of either the rhodopsin or β2AR structures.  However, similar to 
the β2AR structure, it did leave the binding pocket open for ligand binding.  No structural 
information was provided on the short N-terminus.  Another rhodopsin structure that was 
solved was that of light-activated opsin in complex with a synthetic peptide corresponding to 
the C-terminal end of the Gα subunit transducin (Scheerer et al., 2008).  This structure 
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demonstrated differences from the inactive rhodopsin structure in the arrangement of the seven 
transmembrane bundles.  In addition, in the activated rhodopsin structure, the N-terminus 
contained only two antiparallel β-strands, while the inactivated structure contained five β-
strands.  One of the most recent structures to be solved was that of CXCR4 chemokine receptor 
(Wu et al., 2010).  The structure was solved in complex with a small molecule antagonist, IT1t, 
and with a cyclic peptide inhibitor, CVX15.  These antagonists were chosen based on ligand 
solubility, binding affinity and induced protein thermostability.  This structure also contained 
the insertion of T4 lysozyme into IL3.  The N-terminal residues of this structure did not have 
interpretable density and were presumed to be disordered.  Another recent structure to be solved 
was that of the human dopamine D3 receptor (D3R), which again contained the insertion of T4 
lysozyme into IL3 (Chien et al., 2010).  The EL2 is much shorter in the D3R structure when 
compared to the structure of the βAR’s.  Overall, these six crystal structures highlight many of 
the common structural characteristics between GPCRs but also indicate that each GPCR has its 
own interesting structural features.  Historically, the reason for the limited number of crystal 
structures is that using X-ray crystallography for GPCR structure determination can sometimes 
be very complicated.  First, purification of large amounts of GPCRs can be quite difficult.  
Also, many GPCRs are very difficult to crystallize because they require detergents or other 
solvents to solubilise them which can interfere in the crystallization.  Finally, while the recent 
successes described above highlight a bright future, that is based on modifications and ligand 
associations for crystallizing more GPCRs, structural information about N-terminal regions 
remains elusive.    
 NMR takes advantage of the ability of nuclei to absorb electromagnetic energy and 
radiate this energy out at a specific frequency.  This frequency is dependent on the nuclei’s 
environment, which gives information about the structure of the protein.  NMR theory will be 
discussed in more detail in Section 1.3.3.  To date there has been no complete 3D structure of a 
GPCR solved using NMR.  This is because recombinant expression of GPCR proteins is quite 
difficult for cell expression systems.  As well the need for a large amount of pure, isotopically 
labelled protein can be quite expensive to produce.  On top of all this, in order to perform NMR 
on a protein it has to be soluble, which often requires the use of detergents or lipid micelles.  
Therefore, the combination of these factors as well as the limited thermal stability and short 
lifetime of GPCRs has led to the inability to determine a full structure using NMR.  However, 
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the first full structure of a 7TM protein using NMR was recently obtained on the photoaxis 
receptor sensory rhodopsin II (pSRII) from Natronomonas pharaonis (Gautier et al., 2010).  
This structure was obtained with good resolution and is almost identical to the structure 
obtained by X-ray crystallography.  Therefore, recombinant expression systems are improving 
in order to be able to produce large quantities of higher molecular weight proteins.  However, it 
is still very difficult to recombinantly express the larger full length GPCRs, so all current NMR 
structural data has been obtained from fragments of GPCRs (Chung et al., 2002; Conner et al., 
2008; Werner et al., 2008; Zou et al., 2008).  Focusing on data related to the structurally 
enigmatic N-terminal region, a fragment of the human Y4 GPCR containing the N-terminus, 
TM1, TM2 and EL1 was solved using NMR (Zou et al., 2008).  The N-terminus (residues 1-40) 
was found to contain a short helix (residues 5-10), an unstructured portion (residues 11-30) and 
a terminal helix (residues 31-40) which connected the N-terminus to TM1.  A terminal helix 
(residues 39-47) was also found using NMR structural analysis of the yeast GPCR, Ste2p 
(Neumoin et al., 2009).  This demonstrates that NMR can be applied to protein fragments in 
order to solve structural questions for proteins that are very difficult to crystallize.  Another 
important advantage of NMR is that dynamic information about the protein can be obtained, 
whereas in X-ray crystallography only static information is available.  Thus, receptor-ligand 
interactions can be studied using NMR (Tapaneeyakorn et al., 2010). 
 
 
1.3 Saccharomyces cerevisiae 
 Saccharomyces cerevisiae is a species of budding yeast, which is also known as baker’s 
yeast.  S. cerevisiae has been used as a model system for molecular and cell biology research in 
eukaryotes.  It is an extremely useful model system because the molecular bases of 
recombination, replication, cell division, and metabolism are generally conserved between yeast 
and higher eukaryotes, such as mammals.  The life cycle of S. cerevisiae consists of the yeast 
having either two genomes (diploid) or one genome (haploid), and during the life cycle the 
yeast alternates between these two forms using the processes of mating and germination. 
 
 
 
 1.3.1 S. cerevisiae Mating Overview
 The yeast S. cerevisiae 
cell and the mating-type α cell, also known as the 
and MATα are haploid cells, and during mating two opposite cell types fuse to form a 
MATa/MATα diploid.  Mating in 
which recognize receptors on the opposite haploid yeast cell 
(Dohlman, 2002; Dohlman et al.
secrete α-factor pheromone, a tridecapeptide with the peptide sequence WHWLQLKPGQPMY, 
which binds to the GPCR, Ste2p, on 
pheromone with a farnesyl lipid group attached.  The a
YIIKGVFWDPAC and the peptide 
pheromones are essential for initiation of mating.
or lack the required GPCR cannot undergo mating.
 
 
 
 
 
Figure 1.1: Mating of the Yeast 
Mating in S.cerevisiae involves two haploid cells, MATa and MATα, which secrete 
pheromones, a-factor and α-factor, respectively.  The pheromones recognize the receptor on the 
opposite mating type cell, which initiates mating.
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Once a yeast cell is stimulated by pheromone secreted from the opposite cell type, this 
results in activation of the cell’s pheromone receptors and the interacting G proteins.  The G 
protein complex that interacts with Ste2p and Ste3p contains Gpa1 (Gα), Ste4p (Gβ) and 
Ste18p (Gγ).  When the G protein is activated, the Gβγ subunits are released from Gα and the 
Gβγ subunit goes on to bind to three different effectors; the Ste5p complex, the Ste20p protein 
kinase, and the Far1/Cdc24 complex (Figure 1.2) [reviewed in (Bardwell, 2005)].  The Ste5p 
complex involves Ste5p as a binding platform (scaffold) for other proteins.  Ste5p binds to both 
Ste4p (Gβ) and Ste11p protein kinase allowing for Ste11p to be closer to the plasma membrane 
(Pryciak and Huntress, 1998).  Ste20p is a member of the p21-activated protein kinase (PAK) 
family (Lim et al., 1996).  The C-terminal end of Ste20p is bound to Gβγ and Ste20p is 
activated once it binds to the Rho-like G protein, Cdc42 (Ash et al., 2003).  This brings Ste20p 
close to the plasma membrane and to Ste11p.  Ste20p phosphorylates and activates Ste11p 
which initiates the MAP kinase cascade.  The Far1/Cdc24 complex involves the N-terminal end 
of Far1 bound to Gβγ and the C-terminal end bound to Cdc24 (Butty et al., 1998).  Cdc24 is a 
guanine exchange factor for Cdc42.  Therefore, this complex is involved in Cdc42 activation by 
exchanging GDP for GTP on Cdc42.  This allows for binding of Cdc42 to Ste20p and further 
activation of Ste20p.  Once the MAP kinase cascade has been initiated this results in a number 
of changes in the cell.  The cells 1) synthesize cell surface molecules necessary for fusion with 
their mating partners, 2) arrest in G1 phase of the growth cycle in order to synchronize the cell 
cycles of the two mating partners prior to cell fusion, 3) form mating projections that are 
involved in the fusion process, and 4) increase expression of the genes involved in sexual 
conjugation (Dohlman et al., 1991; Herskowitz, 1995; Marsh et al., 1991). 
 
 
 
 
  
 
Figure 1.2: The Yeast Mating Pheromone Response P
The yeast mating pathway is initiated by 
to pheromones.  This activates the G protein complex which dissociates into its subunits, Gα 
and Gβγ.  The Gβγ subunit then goes on to interact with other protein complexes, such as the 
Ste5p complex, the Ste20p protein kinase, and the Far1/Cdc24 complex, which initiates the 
MAPK signalling cascade. 
 
 
 Physical fusion of MATa cells and MATα cells to each other is initiate
agglutination, which involves binding of glycoproteins on the surface of the opposite cells 
(Figure 1.3) (reviewed in (Chen 
fuse, their cell walls must first 
surrounding the junction and degrade the cell wall at the contact site, forming a conjugation 
bridge.  After the cell wall is remodelled, osmotic gradients across the two plasma membranes 
allow for one cell to extend a finger of membrane bound cytoplasm into the other cell.  
Immediately following the membrane contac
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plasma membranes of the cells have fused, the nuclei migrate into the bridge and subsequently 
fuse to produce a diploid nucleus.  This process is termed karyogamy.  All of these processes 
require involvement of cytoskeletal components, such as microtubules and actin structures, and 
the cell wall (Madden and Snyder, 1998).  After the yeast cell fusion is completed, the final 
product is a peanut-shaped zygote with a diploid nucleus.  The mating is completed by 
terminating the pheromone response, through down-regulation of Ste4p. 
 
 
                                         
 
Figure 1.3: The Stages of Yeast Mating and C
After mating is initiated by pheromone signallin
which interact during the agglutination stage th
wall are remodelled which allows for the forma
membrane fusion.  During karyogamy the nu
fusion is complete the pheromone response is te
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1.3.2 Ste2p Role in Mating  
 As was mentioned previously, Ste2p is the mating pheromone GPCR for MATa cells of 
yeast.  When α-factor is secreted from MATα cells, it interacts with Ste2p and initiates mating 
with the opposite yeast cells, as described above.  However, recent studies suggest additional 
roles beyond modulation of signal transduction, leading to G1 arrest.  In particular, 
proteoliposome fusion assays demonstrated that activated Ste2p and Ste3p promote lipid 
mixing and membrane juxtaposition through an interaction between Ste2p and Ste3p (Figure 
1.4) (Shi et al., 2007).  The interaction between Ste2p and Ste3p was confirmed using tandem 
affinity purification, surface plasmon resonance and cellular pull-down assay experiments.  
Mutational analyses highlighted a role for the N-terminal region of Ste2p in mediating these 
effects. In particular two mutants, one with the first 20 amino acids removed (Ste2p∆N20) and 
a second with the first 30 residues removed (Ste2p∆30N), were expressed in a yeast strain 
where the wild type Ste2p receptor was deleted. The Ste2p∆30N receptor resulted in reduced 
signalling and reduced cell cycle arrest (Shi et al., 2007).  However, when the Ste2p∆N20 
receptor was expressed, the result was a strain that exhibited wild-type signalling levels and 
phenotypic characteristics, but when mated with MATα resulted in very low levels of fused 
zygotes (Figure 1.5).  Electron microscopy experiments showed mating arrest at a prezygotic 
stage after cell contact.  Tandem affinity purification and proteoliposome fusion assays 
confirmed that the interaction between Ste2p and Ste3p was eliminated as was the receptor’s 
ability to promote membrane juxtaposition when the first 20 amino acids of Ste2p were deleted.  
Therefore, the prezygotic arrest that was observed when the Ste2p∆N20 mutant was expressed 
was possibly due to not only the mediation of cell wall erosion but the loss of interaction 
between Ste2p and Ste3p.  Mutagenic screening of the N-terminus of Ste2p was completed and 
it was found that mutations at residues Pro15, Ile24 and Ile29 resulted in wild-type levels of cell 
cycle arrest and a significant loss in mating efficiency, similar to what was seen for the 
Ste2p∆N20 mutant  (Figure 1.6) (Shi et al., 2009a).  Hence, these three residues in the N-
terminus play an important role in mediating the mating efficiency of Ste2p, possibly through 
some form of interaction with either/both activated Ste3p and ligand and/or some other 
component.   
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Figure 1.4: Proteoliposome Fusion Assay of Ste2p and Ste3p. 
Fluorescently-labelled liposomes containing Ste2p-(His)8 were mixed with non-labelled 
liposomes containing Ste3p-(His)8 in the presence (red star) or absence (black hexagon) of a- 
and α-factor.  To ensure that the lipid mixing was not due to the pheromones alone, fusion was 
carried out in the presence (blue triangle) or absence (green square) of a- and α-factor with both 
Ste2p-(His)8 and Ste3p-(His)8 absent.  This image is taken from (Shi et al., 2007). 
 
 
 
                      
Figure 1.5: Signalling and Mating Efficiency of Ste2p Mutants. 
A. Halo assay to determine α–factor stimulated signalling in a receptor null MATa yeast strain 
overexpressing (a) Ste2p-GFP, (b) Ste2p∆20N-GFP, (c) Ste2p∆30N-GFP.  Decreasing 
concentrations of α–factor were spotted on positions 1-4. 
B. MATα yeast was mated with receptor null MATa yeast strains overexpressing (lane 1) 
Ste2p-GFP, (lane 2) Ste2p∆20N-GFP, (lane 3) Ste2p∆30N-GFP, and (lane 4) Ste4p.   
These images are taken from (Shi et al., 2007). 
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alo assay to determine α–factor stimulated signalling in a receptor null MATa yeast strain 
rexpressing Ste2p-P15C, Ste2p-I24C, Ste2p-I29C, and WT Ste2p.  Decreasing 
centrations of α–factor were spotted on the plate starting from the upper position and 
ing counter-clockwise. 
ATα yeast was mated with receptor null MATa yeast strains overexpressing Ste2p-P15C, 
p-I24C, Ste2pI29C and WT Ste2p. 
se images are modified from (Shi et al., 2007). 
3 Ste2p Oligomerization 
A large number of studies have shown that GPCRs can interact to form dimers or 
er-order oligomers (Milligan, 2004; Milligan, 2009; Terrillon and Bouvier, 2004).  GPCRs 
 undergo homodimerization (He et al., 2002; Salahpour et al., 2004) or heterodimerization 
dan and Devi, 1999; Marshall et al., 1999; Nelson et al., 2001).  The ability of GPCRs to 
erize or oligomerize has been thought to play a role in receptor functions such as receptor 
enesis, plasma membrane targeting, signal transduction and down-regulation (Bulenger et 
2005; Wang and Dohlman, 2004).  Ste2p has been shown to dimerize using fluorescent 
nance energy transfer (FRET) or bioluminescence resonance energy transfer (BRET) 
hret et al., 2006; Overton et al., 2005; Raicu et al., 2005).  Ste2p has also been shown to 
omerize in vitro using atomic force microscopy and DLS (Shi et al., 2009b).  It has been 
gested that a GXXXG motif within TM1 of Ste2p may mediate the homo-oligomerization 
raction (Overton et al., 2003).   
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1.3.4 Ste2p Structural Studies 
 The 3D crystal structure of Ste2p to date is unknown.  However, through the use of CD 
and NMR analysis, portions of the Ste2p receptor structure have been illuminated.  In addition 
computer modelling has been used to produce a three-dimensional model of Ste2p (Eilers et al., 
2005).  The Ste2p model was compared to a three-dimensional structure of rhodopsin and even 
though these receptors have no sequence homology, they displayed conserved microdomains 
which suggested similarities between the divergent receptors.  This information has given us 
some understanding into the mechamism of action of Ste2p, although the N-terminus was not 
included in the model. 
 To date, very little research has been done on the structure of the N-terminus of Ste2p.  
The only structural information that is known was obtained from a recent NMR analysis of a 
recombinant peptide containing residues 31 to 110 of Ste2p.  This peptide encompassed a 
portion of the N-terminus, transmembrane helix 1 (TM1), the first intracellular loop (IL1), 
transmembrane helix 2 (TM2) and a portion of EL1.  NMR analysis on this peptide found that 
residues 39-47 of the N-terminus of Ste2p were helical (Neumoin et al., 2009).  These residues 
were predicted to interact with phospholipid groups, providing some indication about the 
possible function of the N-terminus of Ste2p.  Some NMR has been performed on the N-
terminal domains of other GPCRs (Ravindran et al., 2009; Ulfers et al., 2002; Zou et al., 2008), 
however because there is no sequence homology, we cannot say anything about the Ste2p N-
terminus from these. 
 Much more structural information has been obtained on the transmembrane domains of 
Ste2p.  The transmembrane domains of GPCRs are predicted to form α-helical structures 
because it is energetically favourable for a peptide to have this conformation in the non-
aqueous interior of the lipid bilayer (Engelman et al., 1986).  Biophysical experiments, such as 
CD, demonstrated that the synthetic transmembrane fragments of all putative 7 TM domains 
from Ste2p tended to form α-helical structures when in 100% TFE (Xie et al., 2000).  However, 
biophysical analysis of the 7 TM domains in sodium dodecyl sulphate (SDS) or dimyristol 
phosphatidylcholine (DMPC) yielded evidence of significant structural diversity.  Most of the 
transmembrane domains were helical, but TM3 and transmembrane helix 6 (TM6) could form 
β-structures.  Specifically, TM6 was highly helical when in TFE and formed a stable β-sheet 
when in DMPC or SDS, demonstrating high conformational flexibility.  NMR analysis of a 
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synthetic TM6 peptide in TFE/H2O (4:1) showed that the peptide was α-helical but that the 
Pro258 residue disturbs the structure (Naider et al., 2001).  Mutagenesis of Pro258 to Leu 
results in a constitutively active receptor with 45% of wild type signalling (Konopka et al., 
1996; Sommers et al., 2000).  Therefore, the conformational changes that TM6 undergoes may 
be significant for receptor activation as well as receptor oligomerization.  This could be the case 
for transmembrane helix 7 (TM7) as well, which was found to contain an α-helical structure 
which is disrupted by Pro290 which produces a large kink in the helix (Estephan et al., 2005; 
Neumoin et al., 2007).  However, NMR analysis on TM1 and TM2 showed that they contained 
very stable helical structures as compared to the flexible TM6 and TM7 (Neumoin et al., 2009).  
Therefore, structural analysis of the transmembrane domains has demonstrated that they are not 
all rigid α-helical structures and instead can display some conformational flexibility which may 
play a role in receptor activation. 
 As with the N-terminus of Ste2p, the C-terminal end has had very little structural 
analysis performed on it.  Using NMR analysis of a recombinant Ste2p peptide encompassing a 
portion of the third extracellular loop (EL3), TM7 and 40 residues of the C-terminus, the C-
terminus of Ste2p was found to be α-helical in both DPC micelles and TFE/water.  However, in 
the DPC micelles, the C-terminus was unstructured after Gln328 while in TFE/water the helix 
extended up until Ala336 (Estephan et al., 2005; Neumoin et al., 2007).  However, this may be 
due to the fact that TFE is a known helix inducer. 
  
 
1.4 Techniques 
 
1.4.1 Circular Dichroism 
 Dichroism is the property of a material to exhibit some absorption when light in 
different polarization states is travelling through it. Usually light is linearly polarized, meaning 
that the electric field component of electromagnetic radiation is oscillating in a single direction, 
usually in a transverse wave (Figure 1.7A).  However, when light is circularly polarized, the 
electric field component rotates while maintaining constant amplitude, essentially producing a 
helix through space (Figure 1.7B).  When the electric field component is rotating counter-
clockwise, this is called left circularly polarized light, and when it is rotating clockwise, it is 
 called right circularly polarized light.  When a chiral molecule is subjected to circularly 
polarized light, the absorption of light circularly pola
different from the absorption of light circularly polarized in the left
therefore the material is said to demonstrate circular dichroism (CD) (Figure 
Shumays and Duffield, 1966; Hennessey and Johnson, 1981; Oakl
difference in absorbance (∆A) between
plotted versus the wavelength of light to produce a CD spectrum. 
 Traditionally, CD has been reported in terms of its ellipticity (θ).  The ellipticity of a 
material refers to the fact that when the ci
and a differential change in absorbance is observed, the magnitudes of the circularly polarized 
light are not the same anymore and therefore the polarized light is no longer circular but more 
elliptical.  While the term ellipticity is dated, it is still used out of tradition.  It is very easy to 
calculate the ellipticity from the change in absorbance (∆A).  
 
 
Figure 1.7: Circular Dichroism Spectroscopy.
A.  Linearly polarized light travels in a single 
B.  Circularly polarized light is made up of two components, right circularly polarized (RCP) 
and left circularly polarized (LCP), of which the electric field components rotate through space 
at the same amplitude. 
C.  When circularly polarized light tr
polarized light have different absorbances which causes the overall polarization to become 
elliptical.  This ellipticity can be measured using circular dichroism sp
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θ=∆A·32.982       (1.1) 
 
Where θ is the ellipticity and ∆A is the change in absorbance between right and left circularly 
polarized light.  The value 32.982 accounts for conversion from electric field vector quantities 
to the angle of ellipticity. 
 
Ellipticity is usually expressed in millidegrees (mDeg).  Typically, a CD spectrum consists of a 
plot of the Molar ellipticity [θ] versus the wavelength of light.  The [θ] can be calculated from 
the ellipticity and takes into account the molar concentration of the sample as well as the 
pathlength of the cell.  Therefore using Beer Lamberts law, the [θ] can be calculated by: 
 
[θ]=100·θ/C·l       (1.2) 
 
 Where C is the concentration of the sample, l is the pathlength of the cell and the factor of 100 
is used for converting the units. 
 
Therefore, the final result is [θ] with units of deg·cm2·dmol-1.  For proteins and peptides it is 
more convenient to express CD in terms of mean residue ellipticity [θ]MR.  [θ]MR reports the 
molar ellipticity for individual protein residues instead of the whole protein molecule.  In order 
to calculate [θ]MR the number of residues needs to be known.   
 
[θ]MR=[θ]/n       (1.3) 
 
Where [θ]MR is the mean residue ellipticity, [θ] is the Molar ellipticity and n is the number of 
amino acid residues. 
 
By displaying the CD spectrum in terms of [θ]MR, this allows for the CD of proteins or peptides 
with very different molecular weights to be compared.   
 CD is a very useful tool for structural analysis of proteins because information about the 
secondary structure can be obtained from the CD spectrum.  Secondary structure can be 
determined by CD spectroscopy in the far UV range (180-250 nm).  At the far UV wavelengths, 
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the chromophore that is observed is the peptide bond (Kelly et al., 2005).  Certain properties are 
indicative of specific secondary structures (Brahms and Brahms, 1980).  For example, a CD 
spectrum with a “w” shape and troughs (also referred to as bands or lines) at around 208 and 
222 nm are indicative of α-helical structure, while a CD spectrum with a “v” shape and a trough 
around 217-220 nm indicates β-sheet secondary structure.  A protein that contains random coil 
will have a characteristic spectrum with a positive band at 212 nm and a trough at 195 nm.  The 
approximate amount of each secondary structure can be determined by analysing the CD 
spectrum using computational analysis (Bohm et al., 1992).  CD spectroscopy can give 
information about the amount of different secondary structures in a protein but not the specific 
residues that participate in that portion of secondary structure.  This is because the CD spectrum 
reflects the secondary structure of the entire protein or peptide.   
 CD spectroscopy is important in protein structural studies for more reasons than just 
secondary structure determination.  CD can be used to compare the structure of the protein 
when it is in different solvents.  This is helpful in determining a suitable solvent system for 
future structural experiments.  In addition, CD can be useful in determining the stability of the 
protein under stress, such as a change in temperature, pH, or the addition of buffers, salts or 
denaturants (Kelly and Price, 1997; Sajedi et al., 2004; Sajedi et al., 2007).  CD spectroscopy 
can also be a valuable tool for analysing the conformational changes a protein undergoes during 
protein-protein or protein-ligand interactions (Boxer et al., 2004).  Overall, CD spectroscopy is 
a very useful technique for analysing the structural characteristics of proteins. 
 
1.4.2 Dynamic Light Scattering  
 Dynamic light scattering (DLS) is a useful technique in protein structural 
characterization because it gives information about the size of biomolecules in solution 
(reviewed in (Li et al., 2004b; Murphy and Tsai, 2006; Nobbmann et al., 2007)).  It can 
therefore determine if a protein is aggregated in solution.  The principle of DLS is based on the 
fact that when light is passed through a solution of biomolecules, part of the light will be 
scattered.  The fluctuations in the scattered light intensity due to Brownian motion can be 
measured using DLS.  An important characteristic of the particles in DLS is the diffusion 
coefficient (D).  The diffusion coefficient of the particles is inversely proportional to the decay 
time of the light scattering fluctuations.  The decay time can be obtained from the time-
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dependant correlation function of the scattered light.  Using the Stokes-Einstein equation, the 
hydrodynamic radius of the particles in the solution can be obtained from the diffusion 
coefficient.   
 
Rh=kBT/6πηD       (1.4) 
 
Where Rh is the hydrodynamic radius with the units nm, kB is the Boltzmann constant, T is the 
temperature, η is the solvent viscosity and D is the diffusion coefficient. 
 
 An assumption made when using the Stokes-Einstein equation is that the particles are 
spherical and non-interacting.  In reality, however, the biomolecules are not spherical, tumbling 
and solvated.  Therefore, this calculation results in the apparent radius of the dynamic 
hydrated/solvated biomolecule, also known at the hydrodynamic radius.  Since the calculation 
is an approximation of the radius, DLS is not useful as a measurement of the exact molecular 
mass.  Instead it is used to distinguish molecules that vary in size by a large amount, such as 
native proteins versus large aggregates.  It is difficult to separate small oligomers such as 
monomers, dimers and trimers from each other and they will often be lumped into the same 
peak. 
 
1.4.3 Nuclear Magnetic Resonance 
 NMR spectroscopy is a very important tool for gathering structural information about 
proteins (reviewed in (Cavanagh et al., 1996; Roberts, 1993; Silverstein et al., 2005; Wüthrich, 
1986)).  NMR spectroscopy is based on the magnetic properties of nuclei.  All nuclei have a 
charge and on some nuclei the charge spins on the nuclear axis.  This produces a quantum 
mechanical property called angular momentum.  The angular momentum is determined using 
the quantum spin number (I) of the nuclei.  The quantum spin number is based on the atomic 
mass and atomic number of a nucleus (i.e. relative number of protons and neutrons).  For 
example, 1H has an odd atomic number (1 proton) so therefore I = ½, while 2H has an even 
atomic mass (1 proton + 1 neutron = 2) and an odd atomic number (1 proton) resulting in I=1.  
Nuclei with a non-zero spin possess a nuclear magnetic moment (µ), which is proportional to 
the angular momentum using the gyromagnetic ratio (γ).  The gyromagnetic ratio is a constant 
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for each nucleus.  The most widely used nuclei in protein NMR spectroscopy are 1H, 13C, and 
15N because they have I = ½ and 2H, which has I = 1.  When the nuclei are placed in a magnetic 
field, the spin ½ nuclei can occupy two energy levels known as the Zeeman levels (Figure 1.8).  
The difference in population between the two energy levels is given by the Boltzmann 
distribution, which determines that there is an excess of population in the lower energy state.  
With the application of an external radiofrequency pulse in a magnetic field, radiation is 
introduced and energy is absorbed by the nuclei, raising it to the higher energy state.  When the 
nucleus is in the external magnetic field, the nuclear spin will precess around the magnetic field 
(Figure 1.9).  The precession frequency is called the Larmor frequency.  As the nuclei transition 
between the two energy states, the spin orientation is reversed.  However, due to the population 
excess in the lower level, as the nuclei transition to the higher level there is absorption of 
energy, which produces a signal.  As the system returns to thermodynamic equilibrium, 
relaxation occurs in the form of spin-lattice (longitudinal) relaxation and spin-spin (transverse) 
relaxation.  Spin-lattice relaxation results from the transfer of energy from the excited protons 
to the surrounding lattice, or nuclei that are vibrating and rotating.  Spin-spin relaxation results 
from interactions between neighbouring nuclei which results in the lifetime of nuclei in the 
excited state to decrease.  The decay of transverse magnetization, or spin-spin relaxation, is 
detected in the receiver and recorded as the corresponding free induction decay (FID) (Figure 
1.10).  The FID is Fourier transformed which produces the NMR spectrum.   
 Information about the protein structure can be interpreted from NMR spectra.  The 
chemical shift (δ) of the nuclei is the variation of the frequency of the nucleus dependent on its 
environment, which is relative to a reference compound.  Each chemically non-equivalent 
nucleus will have a different chemical shift based on the surrounding environment.  For proton 
NMR spectra, each resonance line represents a single proton (or group of protons) in the 
protein.  The chemical shifts of the nuclei can give information about the environment of that 
nucleus.  Therefore, the chemical shifts of specific nuclei can be assigned from the spectra.  For 
a larger molecule such as a protein, assignments of individual nuclei can become extremely 
difficult due to the number of nuclei in the protein.  It is easier to use two-dimensional (2D) 
NMR experiments for protein structure assignments.  2D experiments allow for calculation of 
the distances (through space and through bond) between nuclei and therefore enable overall 
sequential and conformational assignments for the protein. 
  
                                      
Figure 1.8: Zeeman Levels for a Spin ½ Nucleus in a Magnetic F
When a nucleus has a spin number (
magnetic field. When the nucleus is subjected to radiofrequency radiation
between the two levels.  Therefore, if it was in the lower energy level it will transition to the 
higher energy level and vice versa.  The difference in population between the two levels is 
given by the Boltzmann distribution.
 
 
 
                                    
Figure 1.9: Precessing Nucleus in a Magnetic F
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field. 
 
 
22 
 
ield. 
I) of ½, it can occupy two energy levels, 
, 
 
 
ield. 
B0, the nucleus precesses around the magnetic 
-½ or +½ in a 
it can transition 
  
                      
Figure 1.10: Free Induction
Spectrum. 
Initially the transverse magnetization decay is record
period of time (top).  After Fourier Transformatio
(bottom).  This figure is modified from 
 
 
 For protein NMR, the majority of structural 
homonuclear or heteronuclear experiments
FID is recorded as a function o
spectrum that is a function of one frequency variab
signal is recorded as a function of two time variab
evolution time that increases in increments through
when the signal is recorded.  The total sequence of
1.11).  Thus, a pulse sequence is repeated with increa
as a function of t2 for each value of 
to produce a spectrum which con
represented by a topographical map, where one of 
common 2D-NMR experiments that are used in p
(COSY) and total correlation spectroscopy (TOCSY
23 
 Decay and the 
(Iannone, 199
.  In a on
f one time variab
t1.  The FID’s a
tains two frequenc(ppm) (s) ed as the free induction decay (FID) over a 
n of the FID the spectrum is produced 
information comes from 
le, w
les, 
out the experiment
 events is 
sing 
the axes is 
rotein NMR are correlation spectroscopy 
), which measure magnetization transfer 
Corresponding Fourier Transformed 
9). 
multidimensional 
e-dimensional (1D) NMR experiment
le and Fourier-transformed to produce a 
hile in a 2D NMR experiment
t1 and t2.  The t1 time variable is an 
, and the 
called a pulse sequence (Figure 
t1 increments and the FID is recorded 
re Fourier-transformed in both dimensions 
y variables, f1 and f2.  The 2D spectra are 
f1 and the other
 
, the 
, the 
t2 variable is 
 is f2.  Some 
 through bond between the same type of nuclei (homonuclear).  Heteronuclear s
coherence (HSQC) or heteronuclear multiple bond coherence (HMBC) measure the 
magnetization transfer through bond between different types of nuclei (heteronuclear).  As well, 
nuclear Overhauser effect spectroscopy (NOESY) and rotating frame Ov
spectroscopy (ROESY) NMR experiments measure magnetization transfer through space.  For 
example, a very common 2D experiment that is used is COSY.  2D COSY experiments allow 
for observation of the amide proton
(1Hα).  The 1HN-1Hα crosspeaks provide the fingerprint of the amino acid sequence of the 
peptide.  There is a known number of expected crosspeaks in the 
determined using the following equation:
 
N – P + G 
 
Where N is the total number o
number of glycine residues in the peptide. 
                                     
         
Figure 1.11: 2D COSY NMR Pulse S
Pulse sequence for a standard 2
followed by a pulse (p1) which is a varia
Following the pulse is a time delay, 
experiment.  Following another pulse, p2, the 
receiver during the acquisition time (aq)
  
24 
s (1HN) and their interactions with alpha carbon proton
1HN-1Hα region which can be 
 
– 1 = crosspeaks in 1HN-1Hα region   
f residues, P is the number of proline residues and G is the 
  
equence. 
D COSY NMR experiment.  The relaxation delay (d1) is 
ble radiofrequency pulse dependent on the experiment.
t1, which increases in increments over the course of the 
t2 magnetization signals are detected by the 
. 
ingle quantum 
erhauser effect 
s 
 (1.5) 
 
  
25 
 
 
 In order to perform heteronuclear NMR experiments on protein samples, the protein 
must first be isotopically labelled.  The reason behind this is that the most abundant naturally-
occurring isotopes for carbon and nitrogen, 12C and 14N respectively, have nuclei properties that 
make them unfavorable for NMR.  In the case of 12C nuclei, they have an even atomic mass and 
an even atomic number which results in I = 0.  Therefore, they have no spin and are NMR 
inactive.  However, 14N nuclei have an even atomic mass number and an odd atomic number 
which results in I = 1, which causes unfavorable relaxation properties during NMR 
experiments.  In contrast the, relatively rare isotopes 13C and 15N can be used in heteronuclear 
NMR experiments.  However, in order to detect these isotopes, isotopic labelling of a protein 
must be carried out to enrich for their presence allowing detection at relatively low protein 
concentrations.  This can be achieved by producing recombinant proteins in media enriched 
with the required isotope, or an isotopically labelled protein can be chemically synthesized.  
Uniform isotopic labelling is an important tool because it enables/facilitates assignment 
procedures. 
 A disadvantage of protein NMR is that there are size constraints.  Larger proteins have 
slower tumbling rates and shorter NMR signal relaxation times, which leads to reduced 
sensitivity and broad linewidths.  The other problem is the increase in complexity of the NMR 
spectra due to more NMR-active nuclei in larger proteins and therefore more interactions 
between the nuclei.  This results in more signals that overlap in the limited range of 
frequencies.  In order to combat the problem of large proteins, a number of NMR techniques 
are available.  The first is to label proteins with deuterium, which will take the place of 
exchangeable protons, allowing for them to not be observed in the proton spectrum.  The result 
is simplified spectra, increased relaxation time and increased spectral resolution (Gardner and 
Kay, 1998; Goto and Kay, 2000).  The second technique that has been useful in NMR 
spectroscopy of large proteins is transverse relaxation-optimized spectroscopy (TROSY) 
(Pervushin et al., 1997).  TROSY NMR experiments suppress the faster transverse relaxation 
signals that result from the slow tumbling of high molecular weight proteins and selectively 
observe the most slowly relaxing component, which results in sharper lines for amide and 
aromatic groups.  Another disadvantage of NMR is the requirement of a large amount of pure 
protein, which is especially difficult for membrane proteins.  The reason for this is that the 
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signal is averaged a number of times in an experiment and the signal-to-noise ratio is 
proportional to the concentration of the sample and the square root of the number of scans.  
Therefore, a sample with lower protein concentration will require a larger number of scans 
which may result in an impractical length of time for obtaining a satisfactory spectrum.  The 
goal is to provide a protein sample with a high concentration that is still soluble.  This problem 
has been overcome by the use of fusion proteins for recombinant expression in bacteria, as well 
as the use of detergents in NMR experiments for solubilising membrane proteins (Cook et al., 
2010; Gautier et al., 2010; Sanders and Landis, 1995). 
 However, there are many advantages to using NMR spectroscopy for protein structure 
determination.  One advantage is that because the protein sample is in solution, the difficult 
issue of trying to crystallize the protein is avoided.  Another advantage of NMR is that dynamic 
information about the protein can also be obtained from solution NMR spectroscopy 
(Mittermaier and Kay, 2006; Wand, 2001).  This can provide information about protein 
movements on a broad range of timescales.  In addition, NMR can be a useful tool for 
characterizing protein-ligand interactions (Bokoch et al., 2010; Stark and Powers, 2007).  Using 
a technique called chemical shift perturbation, information about the ligand binding interface 
and conformation changes can be obtained. 
 
 
1.5 Objectives 
 Binding of α-factor pheromone to the G-protein coupled receptor, Ste2p, initiates signal 
transduction events that lead to mating of the yeast Saccharomyces cerevisiae.  It has been 
shown that Ste2p and Ste3p interact with each other to promote cell wall degradation and 
possible membrane juxtaposition (Shi et al., 2007).  Experiments performed with a ∆Ste2p 
yeast strain and an N-terminally truncated Ste2p over-expressed resulted in arrest prior to cell 
wall degradation, a loss of interaction between the Ste2p and Ste3p, and a loss of the receptor’s 
ability to promote membrane juxtaposition in vitro.  Specifically, mutagenesis studies have 
shown that residues Pro15, Ile24 and Ile29 from the N-terminus of Ste2p are important for 
mediating the mating efficiency (Shi et al., 2009a).  These results suggest that the N-terminus 
of Ste2p is involved in cell wall degradation and possibly membrane juxtaposition during yeast 
mating, potentially by mediating the interaction with Ste3p.  However, the mechanism by 
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which the N-terminus is modulating these effects remains unknown.  Therefore, the overall goal 
of the work presented in this thesis was to perform structural analyses to gain insight into the 
mechanism of action of the N-terminal region of Ste2p.   
 
The specific objectives of this thesis were: 
1. To obtain, by recombinant or synthetic methods, purified mg quantities of a soluble, 
purified version of a portion of the N-terminus of Ste2p. 
2. To obtain structural information about the N-terminal region of Ste2p by performing 
biophysical analyses, such as CD, DLS and NMR, on the obtained N-terminal Ste2p 
fragments.  
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2.0 MATERIALS AND METHODS 
 
2.1 Reagents 
 The names of the reagents and their suppliers are listed in Table 2.1.  The addresses of 
the suppliers are provided in Table 2.2.     
 
Table 2.1: List of Reagents and Suppliers. 
Reagent: Supplier: 
Acetic acid - glacial Fisher Scientific 
Acetonitrile Fisher Scientific 
Ammonium molybdate Sigma Aldrich 
Ammonium persulfate Sigma Aldrich 
Ammonium sulfate EMD 
Ammonium 15N2 sulphate (15N, 98%+) Cambridge Isotopes 
Ampicillin Sigma Aldrich 
Bacto-Agar BD 
Bacto-Tryptone BD 
Bacto-Yeast Extract BD 
Boric acid EMD 
Bromophenol blue Sigma Aldrich 
Calcium chloride Sigma Aldrich 
Calcium sulfate VWR 
Chloroform Fisher Scientific 
Cobalt chloride Sigma Aldrich 
Coomassie Brilliant Blue G 250 Sigma Aldrich 
Cyanogen bromide Sigma Aldrich 
Deuterium oxide (D, 99.9%) Cambridge Isotopes 
Dimethyl sulfoxide Fisher Scientific 
Formic Acid (88%) Fisher Scientific 
Glucose Sigma Aldrich 
Glycerol Sigma Aldrich 
Glycine Fisher Scientific 
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Guanidine hydrochloride Sigma Aldrich 
Imidazole Sigma Aldrich 
Iron(II) sulfate Fisher Scientific 
Isopropyl β-D-thiogalactopyranoside (IPTG) BioShop 
Magnesium sulfate Fisher Scientific 
Manganese chloride Sigma Aldrich 
β-mercaptoethanol Sigma Aldrich 
Methanol Fisher Scientific 
Nickel-NTA resin Qiagen 
n-octyl-β-D-glucopyranoside (OG) Anatrace 
One Shot TOP10F’ Competent Cells Invitrogen 
1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (LPPG) Avanti Polar Lipids 
pET31b+ Novagen 
1,4-Piperazinediethanesulfonic acid Sigma Aldrich 
Potassium chloride Fisher Scientific 
Potassium phosphate monobasic EMD 
Primers IDT 
Qiagen mini-prep kit Qiagen 
QuikChange Site-Directed Mutagenesis Kit Stratagene 
SeeBlue® Plus2 Pre-stained Standard Invitrogen 
Sodium phosphate dibasic EMD 
Sodium phosphate monobasic EMD 
2,2,2-trifluoroethanol (TFE) Sigma Aldrich 
2,2,2-trifluoroethanol-d2 (TFE-d2) (D, 98%) Cambridge Isotopes 
N,N,N’,N’-tetramethylethylenediamine Sigma Aldrich 
Trifluoracetic acid (TFA) Sigma Aldrich 
Zinc chloride Sigma Aldrich 
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Table 2.2: List of Names and Addresses of Suppliers.     
Supplier: Address: 
Anatrace Maumee, Ohio, USA 
Avanti Polar Lipids Alabaster, Alabama, USA 
BD Mississauga, Ontario, Canada 
BioShop Burlington, Ontario, Canada 
Cambridge Isotopes Andover, Massachusetts, USA 
EMD Gibbstown, New Jersey, USA 
Fisher Scientific Ottawa, Ontario, Canada 
IDT Coralville, Iowa, USA 
Invitrogen Carlsbad, California, USA 
Novagen Gibbstown, New Jersey, USA 
Qiagen Mississauga, Ontario, Canada 
Sigma-Aldrich Oakville, Ontario, Canada 
Stratagene La Jolla, California, USA 
VWR Mississauga, Ontario, Canada 
 
 
 
2.2 Synthetic KKK-Ste2p(14-43)-KKK Peptide 
 Initially, residues 14-43 of Ste2p were chemically synthesized by CanPeptide, Inc. 
(Pointe-Claire, Quebec).  However, CanPeptide Inc. was unable to purify this product by 
HPLC.  Therefore, three lysine residues were added respectively to the N and C-termini of the 
peptide to increase solubility as was successfully carried out previous (Xie et al., 2000).  This 
produced the synthetic 36 residue KKK-Ste2p(14-43)-KKK peptide.  This peptide contained an 
N-terminal acetylation and a C-terminal amidation.  Canpeptide Inc. was able to synthesize and 
purify this peptide by HPLC.  The final peptide sequence was 
KKKDPTYNPGQSTINYTSIYGNGSTITFDELQGKKK.  
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2.3 Bacterial Strains and Media Preparations 
 E. coli BL21-CodonPlus (DE3)-RIL strain (Stratagene, La Jolla, CA) was used for 
plasmid expression and induction of fusion proteins.  One Shot® TOP10F´ competent cells were 
used as the host for propagation of mutagenized plasmid DNA. 
 2x Yeast Extract and Tryptone (2xYT) plates containing ampicillin were used to 
propagate both E. coli strains.  2xYT plates contain 16 g/L Bacto-Tryptone, 10 g/L Bacto-Yeast 
Extract, 5 g/L NaCl and 15 g/L Bacto-Agar in 1 L of distilled water (dH2O).  The media was 
sterilized by autoclaving for 20 mins at 15 psi.  Once the media was cooled to ~50°C, a final 
concentration of 100 µg/mL of sterile ampicillin was added.  The 2xYT media was poured into 
Petri dishes, left to solidify and stored at 4°C. 
 Liquid 2xYT media containing ampicillin was used for small and large scale expression 
of plasmid DNA encoding fusion proteins transformed into E. coli.  2xYT media consisted of 
16 g/L Bacto-Tryptone, 10 g/L Bacto-Yeast Extract, and 5 g/L NaCl in 1 L of dH2O.  The 
media was sterilized by autoclaving for 20 mins at 15 psi.  Once the media cooled, a final 
concentration of 100 µg/mL of sterile ampicillin was added.  The 2xYT media was kept at 4°C 
for long term storage. 
 M9 minimal media containing ampicillin was used for larger scale expression of 
plasmid DNA encoding fusion proteins transformed into E. coli to produce 15N-labelled 
peptide.  M9 minimal media consisted of 6 g/L Na2HPO4, 3 g/L KH2PO4 and 0.5 g/L NaCl in 1 
L of dH2O.  After mixing of the media, it was sterilized by autoclaving for 20 mins at 15 psi.  
After the media cooled, sterile 1 µM FeSO4, 0.1 mM CaCl2, 2 mM MgSO4, 0.2% (w/v) glucose, 
0.1% (w/v) (NH4)2SO4 or 15N-(NH4)2SO4, 3 nM ammonium molybdate, 0.4 µM H3BO3, 30 nM 
CoCl2, 10 nM CaSO4, 80 nM MnCl2, and 10 nM ZnCl2 were added.  In addition, a final 
concentration of 100 µg/mL of sterile ampicillin was added and the M9 minimal medium was 
stored at 4°C. 
 Super Optimal Broth (SOB) media was used for production of BL21-CodonPlus (DE3)-
RIL competent cells.  SOB media contained 20 g/L Bacto-Tryptone, 5 g/L Bacto-Yeast Extract, 
0.5 g/L NaCl, and 10 mM KCl in 1 L of dH2O.  The SOB media was autoclaved for 20 mins at 
15 psi to sterilize and allowed to cool.  A final concentration of sterile 10 mM MgCl2 and 10 
mM MgSO4 was added to the SOB media.  The SOB media was kept at 4°C for long term 
storage. 
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2.4 Molecular Cloning 
 
2.4.1 Preparation of Competent BL21-CodonPlus (DE3)-RIL E. coli Cells 
 Competent cells were prepared according to Inoue et al.  Essentially, five mL of 2xYT 
medium were inoculated with a single colony of BL21-CodonPlus (DE3)-RIL E. coli.  The 
cultures were incubated overnight at 37°C with shaking.  The overnight cultures were used to 
inoculate 100 mL of complete SOB medium, 1:50.  These cultures were incubated at 37°C with 
shaking until the OD600 ≈ 0.4-0.5.  The cultures were transferred to 50 mL Falcon tubes and 
kept on ice for 10 min.  They were then centrifuged at 2500x g for 10 min at 4°C.  The 
supernatant was discarded and the pellet was gently re-suspended in 32 mL of ice cold 
transformation buffer and kept on ice for 10 minutes.  The transformation buffer contained 10 
mM 1,4-piperazinediethanesulfonic acid, 15 mM CaCl2·2H2O and 250 mM KCl.  It was 
adjusted to pH 6.7 using KOH pellets.  After adjusting the pH, 55 mM MnCl2·4H2O was added 
and the buffer was filter sterilized and stored at 4°C.  The re-suspended cells were centrifuged 
again at 2500x g for 10 min at 4°C.  The supernatant was discarded and the cells were gently 
re-suspended in 8 mL ice cold transformation buffer.  Dimethyl sulfoxide was added drop by 
drop, while continually swirling, to a final concentration of 7%.  The competent cells were kept 
on ice for 10 min and aliquoted into sterile 1.5 mL microcentrifuge tubes and stored at -80°C. 
 
2.4.2 Transformation of Competent Bacterial Cells 
 E. coli BL21-CodonPlus (DE3)-RIL (100 µL) or One Shot TOP10F’ (50 µL) competent 
cells were thawed on ice.  To the competent cells, 10 pg of the required plasmid or 5 µL of 
mutagenesis reactions were added and allowed to incubate on ice for 30 min.  The 
transformation reaction was then heat-shocked at 42°C for 30 sec and then incubated on ice for 
another 10 min.  To allow for recovery of the cells, 100 µL of 2xYT medium was added to the 
transformation reaction.  The reaction was then incubated for one hour with shaking at 37°C.  
The transformation reaction was spread onto 2xYT plates with ampicillin and incubated 
overnight at 37°C. 
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2.4.3 Molecular Cloning of Ste2p N-terminal Fragments into pET31b+ 
 Ste2p N-terminal fusion proteins were all expressed from the pET31b+ vector.  The 
pET31b+ vector is useful for high-level expression of peptides.  The vector contains an 
ampicillin resistance gene for selection and places the target gene under the control of a T7 
promoter.  The vector also encodes the ketosteroid isomerase (KSI) gene at the 5’ end of the 
multiple cloning region and six histidine amino acids (HIS tag) at the 3’ end.  The 
pET31b+/KSI-Ste2p(1-71)-HIS and pET31b+/KSI-Ste2p(1-48)-M-HIS constructs were made 
previously in our lab by E. Lukiwski and M. Loewen, respectively.  Briefly, these constructs 
were made by amplifying residues coding for 1-71 or 1-48 of Ste2p from the pTTSH8Q1/Ste2p 
construct using polymerase chain reaction (PCR).  The PCR amplification introduced a 5’ 
AlwNI restriction site and a 3’ XhoI restriction site.  The AlwNI-Ste2p(1-71)-XhoI PCR product 
was purified using agarose gel electrophoresis.  Both the PCR product and the pET31b+ vector 
were digested using AlwNI and XhoI restriction enzymes.  Calf intestinal phosphatase was 
applied to the vector and both digested vector and fragment were purified by agarose gel 
electrophoresis.  They were then ligated using DNA ligase to produce a gene encoding a fusion 
protein that contained the KSI peptide at the N-terminus, residues 1-71 or 1-48-M of Ste2p and 
a C-terminal HIS tag.  These resulting fusion protein products were designated KSI-Ste2p(1-
71)-HIS and  KSI-Ste2p(1-48)-M-HIS fusion protein.  The final gene constructs were 
confirmed by DNA sequencing.  
  
2.4.4 Site Directed Mutagenesis  
 Mutagenesis primers were designed to introduce three lysine residues between residue 1 
(methionine) and residue 2 (serine) of the Ste2p N-terminal fragment, included in the 
pET31b+/KSI-Ste2p(1-48)-M-HIS construct.  Site-directed mutagenesis was carried out using 
the forward primer 5’-CCAGATGCTGATGAAGAAGAAGTCTGATGCGGCTC-3’ as well as 
the complementary reverse primer.  All primers were designed according to the QuickChange 
Site-Directed Mutagenesis Kit guidelines.  The melting temperature (Tm) was calculated using 
the equation in the guidelines and found to be 79.3°C.  Another set of mutagenesis primers 
were designed to introduce three lysine residues between residue 48 (threonine) and the 
following methionine residue of the Ste2p N-terminal fragment included in the construct 
pET31b+/KSI-Ste2p(1-48)-M-HIS.  The mutagenesis was carried out using the forward primer 
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5’-GTTTAGTTAACAGTACTAAGAAGAAGATGCTCGAGCACCACC-3’ and the 
complementary reverse primer.  The Tm was found to be 79.4°C.  The mutagenesis was carried 
out using the QuikChange Site-Directed Mutagenesis Kit, following the manufacturer’s 
protocol.  Essentially, each mutagenesis reaction consisted of (in a total reaction volume of 50 
µL): 1x reaction buffer (10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl, pH 8.8, 2 mM 
MgSO4, 0.1% (v/v) Triton X-100, 0.1 mg/mL of nuclease-free bovine serum albumin), 0.1 mM 
dNTPs, 125 ng each of forward and reverse primers, 70 ng of purified construct and 2.5 U of 
PfuTurbo DNA polymerase.  The mutagenesis thermal cycling conditions were: (1) initial 
denaturation step at 95°C for 30 sec; (2) denaturation step at 95°C for 30 sec; (3) annealing step 
at 55°C for 1 min; (4) extension step at 68°C for 1 min/kb of plasmid length; (5) repeat 17 
cycles from step (2) to step (4).  The mutagenesis reaction was transformed into One Shot 
TOP10F´ Competent Cells, following the manufacturer’s protocol.  Mutagenesis reactions were 
performed consecutively to incorporate the lysines into the two locations yielding a final single 
construct, pET31b+/KSI-M-KKK-Ste2p(2-48)-KKK-M-HIS.  The associated final fusion 
protein product arising from this construct was termed ‘KSI-SK-HIS fusion protein (where SK 
stands for ‘KKK-Ste2p(2-48)-KKK-M’ and/or Stephanie Kendall).  Single transformed 
colonies were grown overnight in 2xYT medium and DNA was extracted from the cells using a 
Qiagen mini-prep kit.  Constructs were confirmed by sequencing.  
 
 
2.5 Recombinant Protein Expression 
 
2.5.1 Fusion Protein Expression Using 2xYT or M9 Minimal Media 
 To start the expression of the fusion protein of interest, a starter culture of 3 mL 2xYT 
medium or M9 minimal medium with 100 µg/mL ampicillin was inoculated with a single 
colony of BL21-CodonPlus (DE3)-RIL E. coli transformed with the appropriate pET31b+ 
based construct from a fresh plate.  The starter culture was incubated for ~16 hours at 37°C 
with shaking until reaching a cell density of OD600 ≈ 0.9-1.0.  A 4 L Erlenmeyer flask 
containing 800 mL of either 2xYT or M9 minimal medium was inoculated 1:400 or 1:50, 
respectively, with the starter culture.  The cultures were incubated at 37°C with continuous 
shaking until an OD600 ≈ 0.4-0.5 was reached.  When the cultures reached this cell density, 0.2 
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mM isopropyl β-D-thiogalactopyranoside (IPTG) was added to induce the production of the 
fusion protein.  The induced cell culture was incubated at 15°C overnight with shaking. 
 
2.5.2 Optimization of Expression Induction Time 
 In order to find the optimal time for induction of fusion protein expression, a time 
course experiment was set up.  Cultures were grown and induced as described in section 2.5.1 
with the induction time varied and 1 mL aliquots were taken from the culture prior to induction 
at 1 hour, 2 hours, 3 hours, 4 hours and 5 hours post-induction.  The 1 mL aliquots were 
centrifuged at 16,000x g for 2 minutes.  The supernatant was aspirated and the cell pellet was 
re-suspended in 100 µL of 50 mM Tris, pH 8.0.  The suspension was sonicated with 100 W 
output for 2 x 20 sec.  After sonication, 100 µL of 2x SDS loading buffer (5% (v/v) β-
mercaptoethanol, 100 mM Tris HCl pH 6.8, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue, 
20% (v/v) glycerol) was added to the suspension.  These samples were the total cell fraction.  In 
order to separate the soluble and insoluble fractions, a 1 mL aliquot of cell culture was 
centrifuged, re-suspended in 100 µL of 50 mM Tris, pH 8.0 and sonicated on ice at 100 W 
output for 6 x 20 sec pulses.  After sonication, the sample was centrifuged for 2 min at 16,000x 
g.  The supernatant was kept as the soluble fraction and the cell pellet was re-suspended in 100 
µL of 50 mM Tris, pH 8.0.  To both the soluble and insoluble fractions, 100 µL of 2x SDS 
loading buffer was added.  All samples were boiled at 100°C for 5 min and run on a 15% SDS-
polyacrylamide gel using polyacrylamide gel electrophoresis (PAGE) as described below in 
section 2.7.1. 
  
2.5.3 Optimization of IPTG Concentration 
 In order to optimize the IPTG concentration for maximum protein production, an IPTG 
concentration dependent experiment was run.  The initial experiment was set up the same as the 
previous induction time experiment, except that the induction time was maintained for five 
hours at 37°C and the concentration of IPTG was varied.  The following IPTG concentrations 
were used; no IPTG, 0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM and 1 mM IPTG.  Again, 1 mL 
aliquots were removed and separated into total cell, soluble and insoluble fractions as described 
above in section 2.5.2.  These samples were all analysed using SDS-PAGE. 
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2.6 Fusion Protein Purification 
 
2.6.1 Ni-NTA Affinity Enrichment 
 After expression of the fusion protein in either 2xYT or M9 minimal medium with 
ampicillin, the cell cultures were harvested by centrifugation at 5,500x g for 15 mins at 4°C.  
After centrifugation, the cell pellet was re-suspended in 15 mL of 50 mM Tris pH 8.0 and 
sonicated on ice with a 100 W output for 6 x 20 sec pulses.  After sonication the sample was 
centrifuged for 15 mins at 13,500x g at 4°C.  The cell pellet was re-suspended in 8 mL 
guanidine hydrochloride binding buffer (6 M guanidine hydrochloride, 5 mM imidazole, 500 
mM NaCl, 20 mM Tris, pH 8.0) and loaded onto 4 mL of Ni-NTA resin.  The Ni-NTA resin 
was prepared according to the manufacturer’s protocol and equilibrated with 10 column 
volumes of binding buffer.  The fusion protein was bound to the resin by shaking at 4°C for 1 
hour.  The column was washed with 2 column volumes of binding buffer, then with another 2 
column volumes of binding buffer with 20 mM imidazole and finally with 2 column volumes of 
binding buffer with 50 mM imidazole.  The fusion protein was eluted with 2 column volumes 
of binding buffer with 1 M imidazole.  The final eluted fraction was dialyzed using a dialysis 
membrane (Spectrum Laboratories, Inc., Rancho Dominguez, CA) with a molecular weight cut 
off of 3500 Da.  The sample was dialyzed in 4 L of dH2O pH 7 for 4 hrs.  This step was 
repeated a total of 4 times and the resulting solution was lyophilized.  Total protein weight was 
estimated based on dry weight of lyophilized protein. 
 
2.6.2 Cyanogen Bromide Cleavage 
 Cyanogen Bromide (CNBr) was used to remove the KSI and His tags from the KSI-
Ste2p(1-71)-HIS and KSI-SK-HIS fusion proteins, yielding either Ste2p (2-54) peptide 
(SDAAPSLSNLFYDPTYNPGQSTINYTSIYGNGSTITFDELQGLVNSTVTQAIM) or SK 
peptide 
(KKKSDAAPSLSNLFYDPTYNPGQSTINYTSIYGNGSTITFDELQGLVNSTKKKM) 
respectively.  The lyophilized fusion protein and CNBr were dissolved separately in 70% (v/v) 
trifluoroacetic acid (TFA) in water.  The reaction was initiated by mixing equal volumes of the 
two solutions together.  The final concentration of protein and CNBr in the reaction was ~20 
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mg/mL and ~0.5 M, respectively.  The cleavage reaction was carried out in the dark, at room 
temperature for either 4.5 hours or 24 hours.  The reaction was stopped by diluting it three-fold 
with water and speed-vacuuming to produce a dry pellet.  The pellet was re-suspended in 50 µL 
of H2O/acetonitrile (ACN) (50:50) and speed-vacuumed.  This step was repeated three times to 
ensure that all of the TFA and CNBr were removed from the sample.  The digests were 
analyzed using SDS-PAGE. 
 Cyanogen bromide cleavage of the KSI-Ste2p(1-71)-HIS fusion protein was tested 
using a number of different solvents.  The cleavage reaction was carried out as described in the 
previous paragraph.  However, both the fusion protein and CNBr were dissolved in one of three 
solvents; 70% (v/v) TFA, 70% (v/v) formic acid or 6 M guanidine hydrochloride.  The 
reactions were all carried out in the dark at room temperature for 24 hours.  All reactions were 
stopped by diluting them three-fold with water and drying them down with the speed-vaccuum.  
The reactions were all washed with H2O/ACN (50:50) and dried down using the speed-vacuum, 
as previously described. 
 
2.6.3 High Performance Liquid Chromatography (HPLC) 
 Purification of the peptide of interest from the other cleavage reaction fragments was 
performed on a Hewlett-Packard/Agilent 1100 series instrument with a quaternary gradient 
solvent system similar to that previously reported (Zheng et al., 2006).  The quaternary gradient 
solvent system can be used with up to four solvents for gradient analysis.  The lyophilized 
CNBr cleavage reaction was re-suspended in 2,2,2-trifluoroethanol (TFE), incubated at 37°C 
for 20 min, and then an equal volume of H2O was added.  The final concentration of the protein 
was ~10 mg/mL.  The lyophilized peptides solubilized to produce a clear solution.  The sample 
was loaded onto a SUPELCOSIL LC-18, 5 µm column (Supelco, Bellefonte, PA, USA) (25 cm 
x 10 mm ID with 2 cm x 4 mm ID guard cartridge) for semi-preparative purification.  The 
solvent gradient system consisted of solvent A (acetonitrile with 0.1% (v/v) TFA) and solvent B 
(water with 0.1% (v/v) TFA).  After injection, solvent A was increased from 5% to 55% over 
25 min, then reduced to 5% solvent A over 10 min (to recondition the column).  The flow rate 
was maintained at 1 mL/min throughout the purification, and elution of the peptide was 
monitored using a diode array detector (DAD), from 200 nm to 280 nm.  The peak fractions 
were collected, pooled and lyophilized.   
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2.7 Protein Analyses 
 
2.7.1 SDS-Polyacrylamide Gel Electrophoresis 
 Protein samples were mixed with 1x SDS gel-loading buffer (2.5% (v/v) β-
mercaptoethanol, 50 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 10% 
(v/v) glycerol) and boiled at 100°C for 5 min.  The majority of protein samples were resolved 
on a Tris-glycine SDS-polyacrylamide gel (15% (v/v) Acrylamide/Bis (37.5:1), 375 mM Tris, 
pH 8.8, 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulfate, 0.04% (v/v) N,N,N’,N’-
tetramethylethylenediamine) with a 5% stacking gel (5% (v/v) Acrylamide/Bis (37.5:1), 125 
mM Tris, pH 6.8, 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulfate, 0.1% (v/v) N,N,N’,N-
tetramethylethylenediamine).  The SeeBlue® Plus2 Pre-stained Standard and 15-20 µL of 
denatured protein samples were loaded onto the SDS gel.  Electrophoresis was carried out using 
the Bio-Rad Mini Protean Tetra cell (Bio-Rad Laboratories, Hercules, CA) in running buffer 
composed of 25 mM Tris-HCl, 192 mM glycine and 0.1% (w/v) SDS.  A constant voltage of 
100 V was applied until the dye band was through the stacking gel.  The voltage was then 
increased to 200 V until the dye band ran off the gel.  Protein bands were visualized by soaking 
the gel in Coomassie staining solution (45% (v/v) methanol, 10% (v/v) glacial acetic acid, 
0.25% (w/v) Coomassie Brilliant Blue G 250) and then de-staining with 30% (v/v) methanol 
and 10% (v/v) glacial acetic acid. 
 
2.7.1.1  SDS-PAGE of CNBr Cleavage Products 
 The dried CNBr cleavage reactions were re-suspended in 2x Tris-tricine sample buffer 
(100 mM Tris-Cl, pH 6.8, 24% (w/v) glycerol, 8% (w/v) SDS, 0.2 M dithiothreitol) and boiled 
at 100°C for 5 mins.  The samples were resolved on a 15% SDS Tris-tricine polyacrylamide gel 
(15% (v/v) Acrylamide/Bis (37.5:1), 1 M Tris-Cl, pH 8.45, 0.1% (w/v) SDS, 1% (w/v) 
glycerol, 0.1% (w/v) ammonium persulfate, 0.04% (v/v) N,N,N’,N’-
tetramethylethylenediamine) with a 4% stacking gel (4% (v/v) Acrylamide/Bis (37.5:1), 1 M 
Tris-Cl, pH 8.45, 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulfate, 0.1% (v/v) N,N,N’,N-
tetramethylethylenediamine).  The SeeBlue® Plus2 Pre-stained Standard and 15-20 µL of 
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denatured CNBr cleavage protein samples were loaded onto the Tris-tricine SDS gel.  
Electrophoresis was carried out using the Bio-Rad Mini Protean Tetra cell (Bio-Rad 
Laboratories, Hercules, CA) with a cathode buffer (100 mM Tris base, 100 mM tricine, 0.1% 
(w/v) SDS) and anode buffer (200 mM Tris, pH 8.9).  A constant voltage of 100 V was applied 
until the dye band was through the stacking gel.  Then the voltage was increased to 200 V until 
the dye band ran off the gel.  Protein bands were visualized using a silver stain protocol.  The 
gels were placed in a fixing solution (32% (v/v) methanol, 10% (v/v) glacial acetic acid, 0.01% 
(v/v) formaldehyde) for at least two hours with shaking.  The gels were washed once with 30% 
(v/v) methanol and twice with distilled water.  The gels were incubated with a solution 
containing 0.02% (w/v) sodium thiosulfate in water for 1 minute.  After rinsing the gels with 
water they were soaked in the silver stain (0.2% (w/v) AgNO3, 0.025% (v/v) formaldehyde, 
0.02% (w/v) citric acid) for 20 minutes.  They gels were washed with water three times and 
then developed until good resolution using developing solution (6% (w/v) sodium carbonate, 
0.02% (v/v) formaldehyde, 0.0004% (w/v) sodium thiosulfate).  The development was stopped 
using a stop solution containing 20% (v/v) methanol and 0.2% (w/v) citric acid. 
 
2.7.2 Matrix Assisted Laser Desorption Ionization – Time of Flight (MALDI-TOF) Mass 
Spectrometry 
 Mass spectrometric analysis was performed in the PBI/NRC Mass Spectroscopy facility 
on an AB SCIEX 4800 tof-tof instrument (AB SCIEX, Concord, ON, CA) equipped with an 
Nd:YAG laser, 355 nm wavelength 3-7ns pulse width 200Hz firing rate.  Four hundred laser 
shots were accumulated and averaged with the laser power set at 4463 arbitrary units.  The 
mass spectrometer was operated in positive ion linear mode scanning from m/z 2000 to m/z 
30000 using the instrument default calibration.  The samples were used as submitted (see 
below) and mixed on the MALDI plate (0.5µL) sample with CHCA matrix (0.5 µL).  
 The cyanogen bromide cleavage reaction was re-suspended in ACN/H2O (50:50) to a 
final concentration of 1 mg/mL.  The sample was solubilised to produce a clear liquid, and then 
sent for MALDI-TOF MS analysis. 
 The spectra were compared to cyanogen bromide theoretical peptide digest of the 
protein with two search engines (1) auto digest simulation within Biolynx (Waters) and (2) MS-
Digest within Protein Prospector (UCSF Mass spectrometry Facility).  
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 The lyophilized samples from the HPLC peaks were dissolved in ACN/H2O (50:50) 
with a final protein concentration of 1 mg/mL and sent for MALDI-TOF MS analysis.  The 
ACN/H2O sample solubilised to produce a clear liquid.   
 
2.7.3 Dynamic Light Scattering (DLS) 
 The dried SK peptide was re-suspended in four different solvents: (i) 10 mM 
Na2HPO4/NaH2PO4 pH 7.0, (ii) TFE/H2O (1:1) (+0.1% (v/v) TFA), (iii) 
chloroform:methanol:water (CHCl3:CH3OH:H2O) (4:4:1), or (iv) 10 mM Na2HPO4/NaH2PO4 
pH 7.0 and 0.1% (w/v) n-octyl-β-D-glucopyranoside (OG).  The final concentration of all 
samples was 0.2 mM.  The solutions were each filtered using a 0.2 µm nanopore filter 
(Millipore, Billerica, MA, USA) and 12 µL of each was loaded into quartz cuvettes.  The DLS 
measurements were performed using a DynaPro-MS800 instrument (Wyatt Technology, Santa 
Barbara, CA, USA) running Dynamics software at 25°C.  The laser was at a wavelength of 830 
nm for obtaining light-scattering measurements at a 90° angle.  Auto-correlated light intensity 
data was converted to the hydrodynamic radius (Rh) using the Stokes-Einstein equation using 
the Dynamics software. 
 
2.7.4 Circular Dichroism (CD) 
 
2.7.4.1 Circular Dichroism Temperature Study of Synthetic KKK-Ste2p(14-43)-KKK 
 To prepare the H2O sample, the chemically-synthesized KKK-Ste2p(14-43)-KKK 
peptide was dissolved in 10 mM Na2HPO4/NaH2PO4 pH 7.0 to a final concentration of 0.1 
mg/mL.  The TFE/H2O sample was prepared by dissolving the KKK-Ste2p(14-43)-KKK 
peptide in 100% TFE and then an equal volume of dH2O was added to make a ratio of 1:1 
TFE:H2O.  The final concentration of the sample was 0.05 mg/mL.  TFA was added to a final 
concentration of 0.1%.  The LPPG sample was prepared by dissolving the KKK-Ste2p(14-43)-
KKK peptide and 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (LPPG), 
separately, in 10 mM Na2HPO4/NaH2PO4 pH 7.0.  The solutions were mixed together to 
produce a final concentration of protein and LPPG of 0.1 mg/mL and 2 mg/mL, respectively.  
The circular dichroism (CD) spectra of the peptides were recorded on a PiStar-180 spectrometer 
(Applied Photophysics, Leatherhead, Surrey, UK) running PiStar software.  The spectrometer 
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was equipped with a water bath for temperature control.  Approximately 20 µL of each sample 
was used in a quartz cuvette with a path length of 0.1 cm.  All spectra were the average of 8 
scans between 260 and 190 nm or 185 nm at an interval of 0.5 nm and a slit width of 6 nm.  The 
spectra were obtained at 20°C, 40°C, 60°C and 80°C.  CD spectra on blanks, corresponding to 
the different solutions without protein dissolved, were collected with the same parameters and 
subtracted from the spectra containing the protein.  The CD intensities were expressed as mean 
residue ellipticities [(deg·cm2)/(dmol·residue)].  Spectra were smoothed over five points to 
reduce the signal-to-noise ratio.  The spectra were also normalized to zero at the 250-260 nm 
region.  Secondary structure analysis of the circular dichroism data was performed using the 
CDNN CD spectra deconvolution software (Applied Photophysics).  
 
2.7.4.2  Circular Dichroism of Recombinant SK peptide 
 The SK peptide was dissolved in 100% TFE and then an equal volume of dH2O was 
added to make a ratio of 1:1.  The final concentration of the sample was 1 mg/mL.  TFA was 
added to a final concentration of 0.1%.  The sample was filtered with a 0.2 µm nanopore filter.  
The circular dichroism spectrum was run on the sample the same as was mentioned for the 
samples in the previous paragraph with a few minor changes.  Approximately 200 µL of sample 
was used in a quartz cuvette with a path length of 1 cm and the spectrum was obtained at room 
temperature.   
 
2.7.5 Nuclear Magnetic Resonance (NMR) 
 
2.7.5.1  NMR of Synthetic KKK-Ste2p(14-43)-KKK 
 Initial NMR experiments were conducted using the chemically-synthesized KKK-
Ste2p(14-43)-KKK (8.7 mg of lyophilized peptide) dissolved in 90% H2O/10% deuterium 
oxide (D2O) which produced a clear solution with a final peptide concentration of ~ 4 mM.  1D- 
proton (1H) with water suppression by excitation sculpting (number of scans=64), phase 
sensitive double-quantum filtered 2D 1H-1H correlated spectroscopy (COSY) with water 
suppression by excitation sculpting (number of scans=96), phase sensitive 2D nuclear 
Overhauser effect spectroscopy (NOESY) with water suppression by excitation sculpting 
(number of scans=112) and phase sensitive 2D total correlated spectroscopy (TOCSY) with 
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water suppression by excitation sculpting (number of scans=112) experiments were run on the 
sample.  The 2D 1H-1H COSY pulse program was double quantum filtered and phase sensitive, 
and used 512 t1 increments.  The mixing time for the NOESY was optimized to 0.2 sec.  The 
mixing time was optimized to 0.035 sec and the relaxation delay was optimized to 3 sec for the 
TOCSY experiments.  The water signal was suppressed using excitation sculpting with 
gradients for all experiments.  The 90 degree pulse was optimized prior to running all 
experiments.  All NMR spectra were recorded at 25 °C on Bruker Avance 500 MHz NMR 
spectrometer (Bruker BioSpin Corporation, Billerica, MA, USA) running TopSpin 2.1 software 
and equipped with a 5 mm TXI cryoprobe.  All 1H dimensions were referenced to the solvent.  
Assignment of the 2D 1H-1H COSY spectrum peaks was performed using the processing 
software, Felix (Molecular Simulations Inc.). 
 
2.7.5.2  NMR of Recombinant SK Peptide 
 NMR experiments were also performed on the SK peptide (12 mg), which was re-
suspended in 50% TFE-d2/40% H2O/10% D2O (0.1% TFA) to a final peptide concentration of 
~4 mM.  1D-1H and 2D 1H-1H COSY experiments were run on the sample as described in 
section 2.7.5.1 except that the time domain parameter was optimized to 256 for the SK peptide.   
 NMR experiments were performed on the 15N-SK peptide (9.4 mg), which was re-
suspended in 50% TFE-d2/40% H2O/10% D2O (0.1% TFA) to a final peptide concentration of 
~3 mM.  1D-1H with water suppression by excitation sculpting (number of scans=64) and 2D 
1H-15N phase sensitive heteronuclear single quantum coherence (HSQC) using via double inept 
transfer, number of scans=96, F1=512, F2=2048) experiments were run on the sample.  
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3.0  RESULTS 
 
3.1 Recombinant Ste2p(2-54) Peptide 
 
3.1.1 The Recombinant Expression and Purification System for Production of KSI-
Ste2p(1-71)-HIS Fusion Protein  
 A requirement for NMR studies is the production of milligram quantities of isotopically 
labelled peptides.  Toward this, an expression system was previously designed to over-express a 
fusion protein containing the N-terminal region of Ste2p, residues 1-71, in E. coli. The 
pET31b+ vector was selected for cloning of the Ste2p peptide because it is optimal for 
production of peptides and small proteins (Figure 3.1).  The pET31b+ vector contains the T7 
promoter (Rosenberg et al., 1987; Studier and Moffatt, 1986).  Therefore, the gene of interest is 
cloned into the pET31b+ vector and is under the control of bacteriophage T7 transcriptional 
machinery, where T7 polymerase is expressed in the bacterial cell.  The pET31b+ vector 
contains a coding sequence for the KSI peptide which is upstream of the unique cloning site, 
where Ste2p(1-71) was inserted.  The KSI peptide is a useful tool in expression of hydrophobic 
peptides because it forces the fusion protein into inclusion bodies, from which the hydrophobic 
fusion protein can be solubilised and purified (Kuliopulos et al., 1987; Kuliopulos and Walsh, 
1994).  In addition the vector contains a coding region for six histidine residues downstream of 
where the Ste2p(1-71) coding fragment was inserted.  This adds a HIS tag on the fusion protein 
which allows for affinity purification using Ni-NTA resin.  Thus, over-expression of this 
construct in E. coli produced the KSI-Ste2p(1-71)-HIS fusion protein which contained Ste2p(1-
71) with an N-terminal KSI tag, which promoted inclusion body formation, and a C-terminal 
HIS tag which allowed for  purification using a Ni-NTA column (Figure 3.2).   
An initial expression was performed in BL21-CodonPlus (DE3)-RIL cells.  These cells 
were chosen, as they were engineered to specifically express selected tRNAs for optimized 
arginine, isoleucine and leucine codon usage and thus maximized recombinant protein 
yield.The total cell extract, insoluble and soluble fractions were analyzed by SDS-PAGE 
(Figure 3.3).  This experiment was performed in order to verify that the fusion protein was 
being expressed into inclusion bodies.  The SDS-PAGE gel confirmed that the majority of the 
 KSI-Ste2p(1-71)-HIS fusion protein was in the insoluble fraction of the total cell extract 
(Figure 3.3, lane 3).   
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Following the washes, KSI-Ste2p(1-71)-HIS fusion protein was eluted with binding buffer 
containing 1 mM imidazole and observed on the gel at the expected molecular weight of 23 
kDa (Figure 3.6, Lane 9).  After elution, the fusion protein was dialyzed to remove the 
imidazole and salts.  The fusion protein was found to be at a high concentration as well as 
highly pure.  After the previously mentioned optimization of the fusion protein expressions 
levels and purification, the total yield was ~70 mg/liter of culture of pure KSI-Ste2p(1-71)-HIS 
fusion protein based on the weight of the lyophilized protein. 
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3.1.4 Cyanogen Bromide Cleavage 
 CNBr is known to cleave proteins specifically at methionine residues by means of 
cleavage at its C-terminal carboxyl group (Figure 3.7) (Gross and Witkop, 1962).  The KSI-
Ste2p(1-71)-HIS fusion protein contains four methionine residues at positions Met1, Met54, 
Met69, and Met71 of the Ste2p(1-71) portion.  Therefore, cleavage of the KSI-Ste2p(1-71)-HIS 
fusion protein will release the peptide of interest, Ste2p(2-54), from the KSI and His tags.  
Initially, the cyanogen bromide cleavage reaction was carried out for 4.5 hours, as was 
previously described in the literature (Estephan et al., 2005). To examine if the cleavage 
reaction was being carried out completely, purified KSI-Ste2p(1-71)-HIS that had not been 
subjected to cleavage, as well as a zero time CNBr cleavage control and a 4.5 hour CNBr 
reaction were examined using SDS-PAGE (Figure 3.8).  After a 4.5 hour CNBr cleavage 
reaction the KSI-Ste2p(1-71)-HIS fusion protein band had almost disappeared while a new 
band appeared at ~14 kDa, corresponding to the expected KSI fragment, as well a band at ~6 
kDa appeared, which corresponds to the expected peptide, Ste2p(2-54) (Figure 3.8, Lane 4).  
After the 4.5 hour cleavage, there also appeared to be a number of other bands which may be 
due to incomplete cleavage of the fusion protein, or degradation of the other peptide fragments.  
It has been shown previously that a longer CNBr cleavage reaction time of 24 hours results in 
completely digested protein (Arevalo et al., 2003; Rodríguez et al., 2003).  Therefore, in order 
to ensure complete digestion of the peptide, all subsequent CNBr cleavage reactions were 
carried out for 24 hours. 
 
 
Figure 3.7:  Cyanogen Bromide Cleavage Reaction. 
Cyanogen bromide cleaves at the C-terminal end of Methionine residues by attacking the 
sulphur of the Methionine residue.  This results in the formation of homoserine lactone at the C-
terminal end of the peptide.  The sulphur replaces the bromide ion in the cyanogen bromide 
forming methyl thiocyanate.  The figure was taken from (Berg et al., 2002). 
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had four peaks, at ~7.5 min, ~9.5 min, ~10.5 min and ~13.5 min respectively (Figure 3.9).  The 
peak fractions from multiple runs were collected, dried down and re-suspended and loaded onto 
a 15% Tris-tricine gel and silver stained.  The resulting gel showed no bands (data not shown).  
Subsequently, the dried samples were re-suspended in ACN/H2O (1:1) and sent for MALDI-
TOF MS analysis.  None of the peak samples contained any of the expected peptide masses 
after CNBr cleavage (data not shown).  The HPLC purification of the Ste2p(2-54) peptide was 
repeated numerous times and many aspects of the purification were reassessed, but the Ste2p(2-
54) peptide was never recovered after the HPLC step.  Every time the CNBr cleavage products 
were loaded onto the column the Ste2p(2-54), KSI and His tag peptides all disappeared.  
 
 
 
 
 
Figure 3.9: HPLC Chromatogram of KSI-Ste2p(1-71)-HIS Fusion Protein CNBr Cleavage 
Products. 
HPLC was performed after CNBr cleavage in order to purify the Ste2p(2-54) peptide from the 
other cleavage fragments.  The chromatogram at 220 nm displays the purification of the CNBr 
reaction products after a 24 hour digest.   
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3.2 Synthetic Ste2p(14-43) and KKK-Ste2p(14-43)-KKK Peptides 
 After purification of the recombinant Ste2p(2-54) peptide proved to be unfeasible, 
CanPeptide Inc. was  contracted to produce a synthetic peptide containing residues 14-43 of 
Ste2p.  The rationale behind choosing residues 14-43 of Ste2p was because this produced a 
smaller peptide, which would hopefully be easy and inexpensive to synthesize and which 
encompassed the residues of interest, Pro15, Ile24 and Ile29.  However, after synthesizing the 
Ste2p(14-43) peptide, CanPeptide Inc. was also unable to purify the peptide by HPLC.  One 
possible factor contributing to these difficulties is the hydrophobic nature of the peptide.  A 
review of the literature indicated that the addition of three lysine residues to both the N and C-
termini of a peptide can decrease peptide hydrophobicity sufficiently to allow for purification of 
hydrophobic peptides by HPLC (Xie et al., 2000).  Therefore, CanPeptide Inc. was asked to 
synthesize the Ste2p(14-43) peptide again with the addition of three lysine residues to both ends 
of the peptide.  The addition of the lysine residues allowed them to synthesize the KKK-
Ste2p(14-43)-KKK peptide and purify it by HPLC.  This peptide was used to assess suitable 
solvent systems for biophysical analyses and for initial structural analysis by CD and NMR.  
 
3.2.1 Circular Dichroism Temperature Study of the Synthetic KKK-Ste2p(14-43)-KKK 
Peptide 
 Circular dichroism analysis of the chemically synthesized KKK-Ste2p(14-43)-KKK 
peptide was carried out in order to determine the secondary structure of the peptide as well as 
the stability of the protein at different temperatures.  Toward this, the solubility of the peptide 
was initially assessed in a number of solvents.  In total, three solvents were tested, (1) 10 mM 
Na2HPO4/NaH2PO4 pH 7.0, (2) TFE/H2O (1:1) with 0.1% TFA, and (3) LPPG (200 mM) in 10 
mM Na2HPO4/NaH2PO4 pH 7.0.  The reason behind choosing three solvent systems was 
because CanPeptide Inc. had demonstrated that the peptide of interest dissolved in H2O to 
produce a clear solution.  However, it was unknown if the peptide solubilised completely.  
Therefore, it was decided to use TFE/H2O as another solvent because TFE/H2O is a very 
common solvent used in protein structural studies and aids in solubilising hydrophobic 
peptides.  In addition, another solvent system that was used was the detergent LPPG in H2O.  
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This solvent was chosen because it had been previously shown to produce higher quality NMR 
spectra and longer sample lifetimes when compared to other traditional NMR solvents 
(Krueger-Koplin et al., 2004).  The samples were prepared following previously described 
methods (Estephan et al., 2005; Neumoin et al., 2009); the peptide was dissolved in 10 mM 
Na2HPO4/NaH2PO4 pH 7.0 and produced a clear solution.  However, when the peptide was 
dissolved in 100% TFE, the protein would not dissolve and produced a cloudy solution.  But, 
upon addition of H2O the peptide dissolved and the solution became clear.  The peptide also 
produced a clear solution when it was dissolved in the LPPG with 10 mM Na2HPO4/NaH2PO4 
pH 7.0.   
 The peptide samples were run on an  π*-180 instrument.  All samples were assessed at 
20°C, 40°C, 60°C and 80°C.  The ellipticity (θ) of the samples were converted to mean residue 
ellipticity ([θ]) and plotted against the wavelength.   
 The CD spectra (Figure 3.10 (A-C)) showed that the KKK-Ste2p(14-43)-KKK peptide 
was somewhat helical and that the helicity of the peptide was increased when in TFE.  The 
helicity of the peptide was determined by the presence of troughs at 208 and 222 nm.  The 
spectra of peptide in the H2O and LPPG solutions looked similar.  The H2O and TFE samples 
appeared to denature at 60°C, while the LPPG sample was already denaturing at 40°C.  The 
ellipticity and wavelength were imported into the CDNN CD spectra deconvolution software 
for structural analysis.  The predicted secondary structure obtained from the software for the 
KKK-Ste2p(14-43)-KKK peptide in H2O and LPPG were similar at 20°C with ~ 42% β-strand 
and 9% α-helix and ~46% β-strand and 9% α-helix, respectively (Table 3.1).  While the 
predicted secondary structure in the TFE sample was ~26% β-strand and 13% α-helix.  This is 
consistent with the known tendency of TFE to increase helical content (Sonnichsen et al., 
1992).  
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gure 3.10: CD Spectra of KKK-Ste2p(14-43)-KKK Peptide.  
e CD spectra of the KKK-Ste2p(14-43)-KKK peptide was obtained in order to determine the 
condary structure of the peptide in different solvents.  The spectra were run at increasing 
mperatures to assess denaturation of the peptide.  A. The CD spectra of KKK-Ste2p(14-43)-
KK peptide in H2O with a peptide concentration of 0.1 mg/mL.  B. The CD spectra of KKK-
e2p(14-43)-KKK peptide in TFE/H2O (1:1) with 0.1% TFA with a peptide concentration of 
05 mg/mL.  C. The CD spectra of KKK-Ste2p(14-43)-KKK peptide in LPPG with 10 mM 
a2HPO4/NaH2PO4 pH 7.0 with a peptide concentration of 0.1 mg/mL. 
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Table 3.1: Predicted Secondary Structure of Synthetic KKK-Ste2p(14-43)-KKK Peptide 
Using CDNN CD Spectra Deconvolution Software. 
 
KKK-Ste2p(14-43)-KKK in H2O 185-260 nm 
20°C 40°C 60°C 80°C 
Helix 9.10% 8.60% 8.70% 8.40% 
Antiparallel 38.50% 42.40% 54.50% 54.80% 
Parallel 3.60% 3.60% 3.90% 3.90% 
Beta-Turn 23.80% 23.40% 21.00% 19.30% 
Rndm. Coil 31.80% 31.00% 26.40% 26.70% 
Total Sum 106.70% 108.90% 114.50% 113.10% 
KKK-Ste2p(14-43)-KKK in TFE/H2O 190-260 nm 
20°C 40°C 60°C 80°C 
Helix 12.50% 10.20% 10.10% 10.30% 
Antiparallel 22.60% 41.00% 45.60% 49.00% 
Parallel 3.70% 4.10% 4.30% 4.50% 
Beta-Turn 27.10% 22.80% 21.20% 20.50% 
Rndm. Coil 37.10% 29.70% 27.70% 26.20% 
Total Sum 103.00% 107.70% 108.90% 110.70% 
KKK-Ste2p(14-43)-KKK in LPPG/H2O 185-260 nm 
20°C 40°C 60°C 80°C 
Helix 8.50% 8.80% 8.90% 8.50% 
Antiparallel 42.20% 53.10% 49.80% 54.10% 
Parallel 3.60% 3.80% 3.80% 3.90% 
Beta-Turn 22.30% 20.40% 20.90% 19.10% 
Rndm. Coil 31.20% 26.60% 27.60% 26.80% 
Total Sum 107.90% 112.70% 111.00% 112.40% 
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3.2.2 Nuclear Magnetic Resonance Spectroscopic Analysis of the Chemically 
Synthesized KKK-Ste2p(14-43)-KKK Peptide. 
 Based on the observed solubility and stability of the peptide in H2O, the chemically-
synthesized KKK-Ste2p(14-43)-KKK peptide was initially dissolved in D2O to a final 
concentration of ~1 mM for NMR analysis.  Initially, basic 2D TOCSY and NOESY 
experiments were carried out to assess the sample quality and spectral resolution for through 
bond and through space interactions.  The preliminary 2D TOCSY and NOESY results were 
promising (data not shown).  Therefore, the 2D TOCSY (Figure 3.11) and NOESY (Figure 
3.12) experiments were repeated with a more concentrated sample, 3.5 mM KKK-Ste2p(14-
43)-KKK peptide in D2O.  The 3.5 mM NMR experiments clearly show interactions between 
amino acid protons.  For example, Figure 3.13 shows an expansion of the 2D-TOCSY from the 
3.5 mM KKK-Ste2p(14-43)-KKK peptide sample demonstrating the interaction between the 
2,6 H’s and 3,5 H’s of the tyrosine residues in the peptide (residues 7, 16 and 20 in the peptide, 
representing Y17, Y26 and Y30 in Ste2p).  The expected chemical shift values for the 2,6 H’s 
and the 3,5 H’s of Tyr are 7.15 ppm and 6.86 ppm, respectively (Wüthrich, 1986).  There are 
two sets of doublets representing the Tyr protons, which are close to the expected proton 
chemical shift, in the 1H spectrum which display interacting cross-peaks in the 2D-TOCSY 
spectrum.  For reference the sequence of the KKK-Ste2p(14-43)-KKK peptide is 
KKKDPTYNPGQSTINYTSIYGNGSTITFDELQGKKK. 
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Figure 3.11: 2D 1H-1H TOCSY Spectrum of KKK-Ste2p(14-43)-KKK Peptide. 
The TOCSY spectrum of the 3.5 mM KKK-Ste2p(14-43)-KKK peptide in D2O was obtained in 
order to observe the through bond interactions between proton residues.  The sample was 
dissolved in 100% D2O so that the only protons that would be observed in the spectrum are 
those that are attached to carbon. The spectrum was obtained at 25°C. 
 
 
Figure 3.12: 2D 1H-1H NOESY Spectrum of KKK-Ste2p(14-43)-KKK Peptide. 
The NOESY spectrum of the 3.5 mM KKK-Ste2p(14-43)-KKK peptide in D2O was obtained in 
order to observe through space interactions between protons.  The sample was dissolved in 
100% D2O in order to only observe the protons attached to carbon residues.  The spectrum was 
obtained at 25°C. 
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was chosen (instead of TOCSY) was because it displays interactions through bonds for three 
bond lengths or less.  Therefore, it is an ideal experiment for showing the crosspeak interactions 
in the 1HN-1Hα region.  This particular COSY experiment is double quantum filtered meaning 
that it only selects those systems with at least two spins, and filters out non-coupled systems 
such as methyl singlets, therefore simplifying the spectrum.  This results in a cleaner spectrum 
which allows for easier interpretation.   
The COSY showed ~30 crosspeaks in the 1HN-1Hα region (Figure 3.15), however, they were 
not resolved enough to be able to find all of the expected 37 crosspeaks.   
 
 
 
 
 
Figure 3.14: 2D 1H-1H COSY Spectrum of KKK-Ste2p(14-43)-KKK Peptide in 90% 
H2O/10% D2O at 25°C. 
The COSY spectrum of the 4 mM KKK-Ste2p(14-43)-KKK peptide in 90% H2O/10% D2O was 
obtained in order to observe the through bond proton interactions.  More specifically, to see the 
interaction between the amide protons(1HN) and alpha carbon protons(1Hα) of the protein.  The 
spectrum was obtained at 25°C. 
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Figure 3.15: Expansion of 2D 1H-1H COSY Spectrum of KKK-Ste2p(14-43)-KKK 
Peptide. 
The previous COSY spectrum was expanded between 3.6 and 5.1 ppm in the F1 and 7.6 and 8.8 
ppm in the F2 in order to observe the crosspeaks in the 1HN-1Hα region.  The KKK-Ste2p(14-
43)-KKK peptide has 36 amino acid residues, which corresponds with 37 1HN-1Hα crosspeaks. 
 
The spin systems corresponding to the six lysine and five threonine amino acids were 
approximately assigned using the program Felix (Figure 3.16 and 3.17).  Generally, the 
chemical shifts of the protons were close to predicted values, with variations in the range of 
0.1-0.4 ppm, with αH and NH protons shifted more than others (Tables 3.2 and 3.3). The side 
chain shifts of the six lysine residues were very easy to distinguish because they all produced 
exactly the same chemical shift which resulted in very large cross peaks. The ε-amino-H of the 
lysine residues are usually not observed in NMR experiments that use water as a solvent 
because of rapid exchange with the water.  However, they are observed in the COSY spectrum 
(Figure 3.16) which indicates that they are possibly modified, which is very common with 
lysine amino groups (Creighton, 1984).  In contrast the lysine backbone proton shifts, while not 
identical, were sufficiently overlapped that identification of individual cross peaks was not 
possible. Similarly all proton shifts arising from the five threonine residues were not identical, 
but again so closely overlapping, it was not possible to distinguish individual cross peaks in this 
spectrum.  An example of the overlap is the crosspeak interaction between the γH and the βH of 
the five threonine residues (Figure 3.17 inset).   
  
Figure 3.16: Connectivity of
Spectrum. 
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Table 3.2: Proton Observed Chemical Shift and Predicted Chemical Shift of the Lysine 
Amino Acids from KKK-Ste2p(14
 
Proton Observed Chemical Shift (ppm)
εNHn 
εCH2 
δCH2 
γCH2 
βCH2 
αH 
NH 
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Figure 3.17: Connectivity of Protons from Threonine Residues 
Spectrum. 
Assignment of the proton connections of threonine residues from the 2D 
spectrum of 4 mM KKK-Ste2p(14
expansion of βH-γH crosspeak region.
 
 
 
 
 
Table 3.3: Proton Observed Chemical Shift and Predicted Chemical Shift of the 
Threonine Amino Acids from KKK
 
Proton Observed Chemical Shift (ppm)
γCH3 
βH 
αH 
NH 
 
 
 
The NH-αH crosspeak interactions for both the lysine and threonine residues were 
overlapped so that individual residues were unable to be assigned (Figure 3.18).  Use of a 
higher field magnet for future NMR experiments may be useful to separate these resid
62 
from 2D 
-43)-KKK peptide in 90 % H2O/ 10% D2O at 25°C.
 
-Ste2p(14-43)-KKK. 
 Predicted Chemical Shift (ppm)
0.99-1.07 1.2
3.96-4.10 4.2
4.06-4.15 4.
7.98-8.05 8.2
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1H-1H COSY 
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ues.  
 However, even though a few assignments were able to be made, the proton spectrum in general 
contained fewer peaks then expected with a lot of broad peaks which indicates that the peptide 
was possibly aggregated. 
 
 
 
 
Figure 3.18: Expansion of 2D 
Crosspeaks. 
The COSY spectrum was expanded between 3.6 and 5.1 ppm in the F
the F2 in order to observe the crosspeaks in the 
threonine crosspeaks was performed using Felix.
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3.3  KKK-Ste2p(2-48)-KKK-M (SK Peptide) 
 
3.3.1 Molecular Cloning and Mutagenesis of pET31b+/KSI-Ste2p(1-48)-HIS 
 In light of the success achieved with the synthetic peptide containing the terminal Lys 
residues, it was decided to shift the focus back to a recombinant Ste2p peptide that could be 
isotopically labelled to enable heteronuclear NMR experiments for more efficient structural 
elucidation. Therefore, lysine codons were introduced into a pET31b+/KSI-Ste2p(1-48)-M-
HIS construct (already available in the laboratory), which would hopefully allow for the 
purification of the final recombinant peptide by HPLC.  The reason the pET31b+/KSI-Ste2p(1-
48)-M-HIS construct was chosen for mutagenesis over the longer Ste2p(1-71) construct that 
was used initially was to eliminate the portion of the TM1 domain that was included in the later 
construct, which was most likely increasing the hydrophobicity of the protein and contributing 
to the purification problems.  Therefore, the recombinant studies were continued on a shorter 
portion containing only the N-terminal residues 1-48.  Mutagenesis of the construct was 
performed to insert three lysine residues between the first methionine residue of the Ste2p 
peptide and the second residue, serine.  Insertion mutagenesis was completed in two sequential 
steps, with the construct mutated at the ‘N-terminal’ region first.  Upon confirmation of 
successful insertion at the first site, this mutated construct was prepared and used as the 
template for the second round of mutagenesis to insert three lysines at the ‘C-Terminal’ site.  
After the mutagenesis was completed, the final construct was confirmed by sequencing and 
named pET31b+/KSI-M-KKK-Ste2p(2-48)-KKK-M-KSI.   
 
3.3.2 Expression and Purification of the SK Fusion Protein 
 The pET31b+/KSI-M-KKK-Ste2p(2-48)-M-KKK-HIS construct was transformed into 
BL21-CodonPlus (DE3)-RIL E. coli and produced the KSI-M-KKK-Ste2p(2-48)-KKK-M-HIS 
fusion protein, which from this point forward shall be referred to as the SK fusion protein.  A 
large scale expression was carried out to assess production of the SK fusion protein.  The SK 
fusion protein contains the M-KKK-Ste2p(2-48)-KKK-M peptide with an N-terminal KSI tag 
and a C-terminal HIS tag theoretically yielding a fusion protein of ~22 kDa (Figure 3.19).  
After protein expression was induced by IPTG, an aliquot of the culture was removed and 
separated into the total cell, insoluble and soluble fractions.  The remaining culture was 
 prepared and applied to a Ni-NTA column as described in the methods. 
eluted using binding buffer with 1 M imidazole
analysed using SDS-PAGE (Figure 
insoluble fraction of the cell lysate
near homogeneity (Figure 3.20
peptide was found to be ~70 mg of 
 
Figure 3.19: The SK Fusion P
The SK fusion protein contains an N
become insoluble.  The M-KKK
two Met residues at Met1 and a terminal Met residue.  The Met residues allowed for cleavage 
of the fusion protein by CNBr in order to liberate the peptide, KKK
known as the SK peptide from the SK fusion protein.  The HIS tag was used for purification of 
the fusion protein by Ni-NTA resin.  The predicted molecular weight of the SK fusion protein is 
~22 kDa. 
 
Figure 3.20: Ni-NTA Purification
SDS-PAGE was used to analyze the cell extracts of BL21
large-scale expression to observe the levels of SK fusion protein in the tot
soluble fractions.  SDS-PAGE was also used to observe the purity and l
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3.3.3 Cyanogen Bromide Cleavage of SK Fusion Protein 
 Cyanogen bromide cleavage was performed to digest the SK fusion protein at the C-
terminal end of methionine residues.  This reaction should produce the peptide of interest KKK-
Ste2p(2-48)-KKK-M, which was named the SK peptide.  Following CNBr cleavage in 70% 
TFA,   the reaction was terminated and resulting products washed three times by consecutive 
drying by speed-vaccum and re-suspension in ACN/H2O (1:1) to make sure that all traces off 
TFA and CNBr were removed.  The dried protein yield was ~70 mg per litre of culture, 
indicating very little loss of the protein during this step. 
 
3.3.4 HPLC Purification of SK Peptide 
 HPLC purification was used to isolate the SK peptide from the KSI and HIS tag 
digested fragments.  The lyophilized protein from the CNBr cleavage was dissolved in TFE to 
produce a clear solution.  An equal volume of H2O was added and no precipitant formed.  The 
final protein concentration was ~10 mg/mL.  The sample was injected onto the C18 column in 
100 µL volumes and yielded the chromatogram in Figure 3.21 upon elution using an ACN/H2O 
gradient system.  Fractions for peaks at ~16 min, ~21.5 min, ~25 min, ~31.5 min and ~33 min 
were collect respectively.  The respective peaks were pooled from multiple HPLC runs and 
lyophilized. 
 
 
Figure 3.21: HPLC Chromatogram of SK Fusion Protein CNBr Cleavage Products. 
HPLC was performed in order to purify the SK peptide from the other CNBr cleavage 
fragments.  The chromatogram is at 220 nm.  (Reverse-phase HPLC using preparative C18 
column with ACN/H2O + 0.1% TFA solvent system) 
 
 3.3.5 Mass Spectrometry of SK Peptide Purification 
 After drying down the HPLC peak samples, there was ~11.5 mg of the 33 min peak, but 
only ~0.5 mg of the 16, 21.5, 25 or 31.5 min peaks.  Each of these was re-suspended in 
ACN/H2O at a final concentration of 1 mg/mL and sent for MALDI-TOF MS analysis.  The 
MALDI-TOF spectrum of the 33 min peak contained two prominent peaks (Figure 3.22).  The 
first peak at 5885 m.u. corresponded to the SK peptide, while the second peak at 6142 m.u. 
corresponded to the LM-KKK-Ste2p(2-48)-KKK-M peptide (LM-SK-peptide; Table 3.2).  The 
only difference between these two peptides was that the larger peptide had one missed cleavage 
and contained two extra amino acids, one leucine and one methionine.  The ratio of these 
peptides in the dried fraction was approximately 70% SK peptide and 30% LM-SK peptide 
based on the MS peak profiles.  The final dried peptide weight was 11.5 mg, which taking 
molecular weight differences into consideration, represented a 38% overall yield of SK peptide 
from purified SK fusion protein. 
 
 
Figure 3.22: MALDI-TOF MS
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Table 3.4: Predicted Mass of Peptides after Cyanogen Bromide Cleavage of SK Fusion 
Protein. 
 
Peptide Mass Sequence Missed 
cleavage 
Modifications 
SK 5888.56 KKKSDAAPSLSNLFYDPTYNPGQSTINYT
SIYGNGSTITFDELQGLVNSTKKKM(Hsl) 
0  
LM- SK 6129.08 LMKKKSDAAPSLSNLFYDPTYNPGQSTI
NYTSIYGNGSTITFDELQGLVNSTKKKM(
Hsl) 
1  
LM- SK 6145.08 LMKKKSDAAPSLSNLFYDPTYNPGQSTI
NYTSIYGNGSTITFDELQGLVNSTKKKM(
Hsl) 
1 1 oxidation 
KSI 13416.9 HTPEHITAVVQRFVAALNAGDLDGIVAL
FADDATVEDPVGSEPRSGTAAIREFYAN
SLKLPLAVELTQEVRAVANEAAFAFTVSF
EYQGRKTVVAPIDHFRFNGAGKVVSIRA
LFGEKNIHACQM(Hsl) 
0  
His tag 1083.49 LEHHHHHH 0  
 
 
 
 
3.3.6 Dynamic Light Scattering of the Recombinant SK Peptide 
 Based on the NMR results from the synthetic KKK-Ste2p(14-43)-KKK peptide, it was 
possible that the SK peptide might be aggregated.  Therefore, DLS was carried out in order to 
determine if the purified SK peptide was prone to aggregation.  The dried SK peptide from the 
33 min HPLC peak was re-suspended in either TFE/H2O, CHCl3:CH3OH:H2O, 10 mM 
Na2HPO4/NaH2PO4 pH 7.0 or 10 mM Na2HPO4/NaH2PO4 pH 7.0 and OG detergent to a final 
concentration of 0.2 mM.  OG was used during DLS instead of the previously used LPPG 
because it was determined that a deuterated form of LPPG was no longer commercially 
available.  If in future NMR experiments detergents were required then a deuterated form 
would be needed.  Therefore, OG was selected to be used for DLS because a deuterated form 
was available for future use.  The TFE/H2O and CHCl3:CH3OH:H2O samples solubilised to 
produce a clear liquid.  However, both of the H2O samples had a large amount of precipitate.  
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All of the samples were filtered through a 0.2 µm filter and analysed using DLS.  The TFE/H2O 
sample showed no aggregates (Figure 3.23), with the majority of the sample having a radius of 
1 nm, corresponding to a molecular weight close to the SK peptide.  The CHCl3:CH3OH:H2O 
sample was unable to be analyzed by DLS due to the solvent background being too high.  The 
10 mM Na2HPO4/NaH2PO4 pH 7.0 sample showed considerable aggregation (Figure 3.24), 
with most of the protein having a radius in the highest range.  The 10 mM Na2HPO4/NaH2PO4 
pH 7.0 and OG sample yielded a radius of ~0.45 nm (Figure 3.25), which corresponds to the 
buffer, meaning that there was little to no peptide in the sample.  Therefore, the SK peptide was 
most likely aggregated and filtered out of the sample in this last condition.   
 
 
 
Figure 3.23: DLS of the SK Peptide in TFE/H2O (1:1) (+0.1% TFA). 
DLS was performed on the SK peptide in order to determine if the peptide was aggregated in 
TFE/H2O with TFA.  The hydrodynamic radius of the sample was measured and this is an 
indicator of the approximate molecular weight of the molecules in the solution. 
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Figure 3.24: DLS of the SK Peptide in 10 mM Na2HPO4/NaH2PO4 pH 7.0.  
DLS was performed on the SK peptide in order to determine if the peptide was aggregated in 10 
mM Na2HPO4/NaH2PO4 pH 7.0.  The hydrodynamic radius of the sample was measured and 
this is an indicator of the approximate molecular weight of the molecules in the solution. 
 
Figure 3.25: DLS of the SK Peptide in 10 mM Na2HPO4/NaH2PO4 pH 7.0 and 0.1% OG. 
DLS was performed on the SK peptide in order to determine if the peptide was aggregated in 10 
mM Na2HPO4/NaH2PO4 pH 7.0 and OG.  The hydrodynamic radius of the sample was 
measured and this is an indicator of the approximate molecular weight of the molecules in the 
solution. 
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3.3.7 Circular Dichroism of the Recombinant SK peptide 
 Circular dichroism was performed on the SK peptide in order to assess the secondary 
structure of the peptide in different solvents.  Initially, the same four solvents were used as in 
the DLS experiments.  The samples were prepared following previously described methods 
(Estephan et al., 2005). However, after filtering the samples, no CD signal was observed for 
either of the H2O samples suggesting there was no protein in solution after filtering.  This 
correlates with DLS results that suggested that they were most likely both aggregated and 
therefore the peptide was filtered out of the samples.  Also, the CHCl3:CH3OH:H2O sample was 
not able to be analyzed using CD because the chloride in the solvent absorbs in the low UV 
region making it impossible to see the CD spectrum of the SK peptide in this region.  
Therefore, the only sample that CD was performed on was the SK peptide dissolved in 
TFE/H2O (+0.1% TFA).  The sample was run on the π*-180 instrument.  The ellipticity (θ) of 
the samples were converted to mean residue ellipticity ([θ]MR) and plotted against wavelength 
(Figure 3.26).  The spectrum shows that the peptide was able to be solubilised in the TFE/H2O 
and the overall shape of the spectrum is similar to that of the synthetic KKK-Ste2p(14-43)-
KKK peptide.  The CD spectrum in figure 3.26 displays peaks at 208 and 222 nm which 
indicates the presence of α–helical structure, which was similar to what was seen for the 
synthetic peptide in TFE/H2O in figure 3.10B. 
 
 
 
Figure 3.26: CD Spectrum of the SK Peptide in TFE/H2O (0.1% TFA).  
The CD spectrum of the SK peptide was acquired in order to determine the secondary structure 
of the peptide in TFE/H2O with TFA.  The spectrum was obtained at 25°C and the SK peptide 
concentration was ~0.2 mM. 
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 The ellipticity and wavelength were imported into the CDNN CD spectra deconvolution 
software for structural analysis.  The predicted secondary structure obtained from the software 
for the SK peptide in TFE/H2O (1:1) (+0.1% TFA) was ~52% β-strand and 6% α-helix with a 
predicted beta-turn (Table 3.3).  When compared to the predicted structure from CD analysis of 
the KKK-Ste2p(14-43)-KKK in TFE/H2O, which was ~ 26% β-strand and 13% α-helix with an 
expected beta-turn, it indicated that a larger portion of the longer recombinant SK peptide was 
β-strand with relatively less α-helix. 
 
Table 3.5: Predicted Secondary Structure of SK Peptide in TFE/H2O (1:1) (+0.1% TFA) 
Using CDNN CD Spectra Deconvolution Software. 
190-260 nm 
Helix 6.30% 
Antiparallel 48.80% 
Parallel 3.70% 
Beta-Turn 16.70% 
Rndm. Coil 29.00% 
Total Sum 104.50% 
 
 
3.3.8 Nuclear Magnetic Resonance of the Recombinant SK Peptide 
 Based on the DLS and CD data, TFE was chosen as a suitable solvent for NMR analysis 
of the SK peptide. The SK peptide was re-suspended in 50% TFE-d2/40% H2O/10% D2O 
(0.1% TFA) to a final concentration of 4 mM.  This solvent yielded a clear solution of the 
peptide for NMR analysis.  The SK peptide has 54 amino acid residues which theoretically 
should yield 54 crosspeaks in the 1HN-1Hα region.  A 1D-1H spectrum was run on the SK 
peptide sample (Figure 3.27).  The spectrum displayed a number of sharp peaks; however the 
peaks were broad and lacking in number for the size of the peptide.  A typical 1D-1H spectrum 
for a peptide of approximately the same size would contain a larger number of sharp peaks, 
such as the 1D-1H spectrum of the 47-residue peptide of Factor IX (Figure 3.28).  None the 
less, a 2D 1H-1H COSY spectrum was run on the sample (Figure 3.29).  The COSY showed 
almost no crosspeaks in the 1HN-1Hα region (around 7 or 8 ppm), which suggests that the 
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peptide may be aggregated at 4 mM concentration.  The DLS and CD experiments were 
performed at a concentration of 0.2 mM and in theory this is the only variable between the 
experiments.  Therefore, the high concentration may be contributing to the aggregation. 
 
 
 
 
Figure 3.27: 1D 1H Spectrum of SK Peptide. 
The 1D proton spectrum of the 4 mM SK peptide was obtained in 50% TFE-d2/40% H2O/10% 
D2O in order to observe the total number of proton peaks for the peptide.  The spectrum was 
obtained at 25°C. 
 
 
 
 
 
Figure 3.28: 1D-1H spectrum of Factor IX residues 1-47. 
The 1D proton spectrum of residues 1-47 of Factor IX was obtained using a peptide 
concentration of 2.1 mM in H2O, pH 5.2 at 25°C.  This spectrum was taken from (Freedman et 
al., 1995). 
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Figure 3.29: 2D 1H-1H COSY Spectrum of SK Peptide. 
The COSY spectrum for the 4 mM SK peptide in 50% TFE-d2/40% H2O/10% D2O was 
acquired in order to observe the through bond proton interactions in the 1HN-1Hα region.  The 
spectrum was obtained at 25°C. 
 
 
3.4 SK Peptide in Enriched 15N M9 Minimal Medium 
 
3.4.1 Purification of SK Fusion Protein from M9 Minimal Medium 
 In order to enable NMR structural analyses at lower protein concentrations, the 
pET31b+/KSI-M-KKK-Ste2p(2-48)-M-KKK-HIS construct was transformed into BL21-
CodonPlus (DE3)-RIL E. coli and a large scale expression in M9 minimal medium 
supplemented with 15N-labelled ammonium sulphate was performed in order to produce an 15N-
labelled SK fusion protein.  Labelling with 15N allows 2D heteronuclear 15N-1H NMR 
experiments to be performed, which facilitiates structural resolution from lower concentration 
protein samples.  After expression of the SK fusion protein in the 15N-labelled M9 minimal 
medium, the fusion protein was purified as in Section 2.6.1.  The total dried 15N-SK fusion 
protein amount was ~47 mg/L of M9 minimal medium.  The 15N-SK fusion protein was cleaved 
using cyanogen bromide as in Section 2.6.2 and dried down using the speed-vacuum. 
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3.4.2 HPLC Purification of 15N-labelled SK peptide  
 HPLC purification was used to isolate the 15N-SK peptide in the 15N-SK fusion protein 
from other digested fragments.  The lyophilized protein from the CNBr cleavage was dissolved 
in TFE to produce a clear solution.  An equal volume of H2O was added and no precipitant 
formed.  The final protein concentration was ~10 mg/mL.  The sample was injected onto the 
hydrophobic reverse phase C18 column in 100 µL volumes and yielded the chromatogram in 
Figure 3.30 upon elution using an ACN/H2O gradient system.  Fractions for peaks at ~13 min, 
~16 min, ~20 min, ~27 min and ~35 min were collect respectively.  The respective peaks were 
pooled from multiple HPLC runs and lyophilized. 
 
 
 
 
Figure 3.30: HPLC Chromatogram of 15N-labelled SK Fusion Protein CNBr Cleavage 
Products. 
HPLC was performed in order to purify the 15N-SK peptide from the other CNBr cleavage 
fragments.  The chromatogram is at 220 nm.   
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3.4.3 Mass Spectrometry of 15N-labelled SK Peptide Purification 
 After drying down the HPLC peak samples, there was no protein from the 13, 16, 20, 
and 27 min peaks.  However, the 35 min peak contained 9.5 mg of protein.  The 35 min peak 
was re-suspended in ACN/H2O at a final concentration of 1 mg/mL and sent for MALDI-TOF 
MS analysis.  The MALDI-TOF spectrum of the 35 min peak contained a number of prominent 
peaks in the range from 3000-4000 mass units (Figure 3.31).  This range is considerably lower 
than the expected mass of 15N-labelled SK peptide, which is ~5950 mass units.  There are a few 
peaks around 5950-6027 m.u. but they are very small and not the prominent peptides in the 
sample.  Therefore, it is possible that this sample had degraded prior to MS analysis. 
 
 
 
Figure 3.31: MALDI-TOF MS of 35 min Peak from HPLC Purification. 
After drying down the 35 min peak from the HPLC purification in Figure 3.30, the sample was 
dissolved in ACN/H2O and sent for MS analysis.  MALDI-TOF MS was performed on the 35 
min peak in order to determine the mass of the peptide that was purified off the column.   
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3.4.4 Nuclear Magnetic Resonance of 15N-labelled SK Peptide 
 The 15N-labelled SK peptide from the 35 min HPLC peak was re-suspended in 50% 
TFE-d2/40% H2O/10% D2O (0.1% TFA) to a final peptide concentration of ~3 mM.  A 2D 1H-
15N HSQC was run on the sample in order to observe interactions between the nitrogens and 
their attached protons (Figure 3.32).  While the sample produced a number of clear interactions, 
there was considerable overlap for the most part, suggesting aggregation or degradation.  This 
correlates with the observed degradation identified by previous MS analysis.   
 
 
                
 
Figure 3.32: 2D 1H-15N HSQC Spectrum of 15N-labelled SK Peptide. 
The 1H-15N HSQC spectrum was obtained using 3 mM 15N-labelled SK peptide in 50% TFE-
d2/40% H2O/10% D2O in order to observe all proton and nitrogen interactions.  The spectrum 
was obtained at 25°C. 
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4.0  DISCUSSION 
 
 The goals of this project were to obtain purified mg quantities of a soluble version of a 
portion of the N-terminus of Ste2p and to acquire structural information about this region by 
performing biophysical analysis on the soluble N-terminal Ste2p fragments.  Initially, residues 
2-54 of Ste2p were purified as part of a fusion protein and cleavage of this protein produced 
Ste2p(2-54) peptide.  Unfortunately, the Ste2p(2-54) peptide was unable to be purified using 
HPLC.  Therefore, a peptide containing residues 14-43 was synthesized but again was unable to 
be purified using HPLC.  However, the addition of three lysine residues to both ends of the 
peptide allowed for synthesis and purification of the KKK-Ste2p(14-43)-KKK peptide.  This 
peptide was subjected to biophysical analysis which yielded CD spectra that indicated peptide 
secondary structure and initial NMR experiments that were promising.  Following this, a 
shorter recombinant version of the N-terminus of Ste2p, containing residues 2-48 with the 
additional terminal lysine residues, was successfully expressed as a fusion protein in E. coli.  
The fusion protein was effectively cleaved in order to liberate the Ste2p N-terminal peptide 
fragment, SK peptide.  The SK peptide was purified, in mg quantities, from the other cleavage 
products using HPLC and these results were confirmed using MS analysis.  DLS analysis 
determined that the SK peptide was aggregated when dissolved in H2O but not aggregated in 
TFE/H2O.  CD analysis of the SK peptide when it was dissolved in TFE/H2O showed that it 
demonstrated secondary structure.  NMR analysis of both the unlabelled and 15N-labelled 
peptide was performed on the SK peptide. 
 
 
4.1 Ste2p(2-54) Peptide Purification 
 Originally, a longer N-terminal fragment of Ste2p was going to be used for structural 
analysis based on naturally occurring methionines as cleavage sites and the concept of ‘the 
longer the peptide, the more biologically relevant the resulting structure’.  After purification of 
the fusion protein containing residues 1-71 from Ste2p, the fusion protein was cleaved using 
cyanogen bromide and attempts to separate the fragments were made using HPLC.  However, 
after many experiments were performed, the Ste2p(2-54) peptide fragment continually was 
unable to be eluted off the HPLC column.  This issue was very difficult to resolve and 
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approximately a year was focused on trying to determine why the Ste2p(2-54) peptide was lost 
during HPLC purification.  A number of factors were tested to determine if they affected the 
HPLC purification.  A few of these were changing the HPLC gradient solvents, as well as 
CNBr cleavage solvents and reaction length.  Also a number of solvents were tested to 
solubilise the protein before loading onto the HPLC column.  However, none of these changes 
resulted in the successful purification of the peptide by HPLC.  This may be due to the fact that 
the Ste2p(2-54) peptide contained residues 50 - 54 which are predicted to be part of 
transmembrane 1 of Ste2p.  Of these residues, Ala52, Ile53 and Met54 are considered 
hydrophobic at pH 7.0 with Thr50 and Gln51 being considered neutral (Monera et al., 1995).  
A hydrophobicity plot of the Ste2p(2-54) peptide confirmed that both ends of the peptide 
contained amino acid residues that were quite hydrophobic (Figure 4.1).  Therefore the peptide 
was possibly too hydrophobic to be purified using a reverse-phase C18 column.   
 
 
 
Figure 4.1: Hydrophobicity Plot of the Ste2p(2-54) Peptide. 
The hydrophobicity of the Ste2p(2-54) peptide was analyzed using ProtScale and based on the 
Kyte and Doolittle Hydropathicity model (Kyte and Doolittle, 1982).  Areas above 0 are 
considered to be hydrophobic and areas below 0 are considered to be hydrophilic. 
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4.2 Synthetic Ste2p(14-43) Structural Analysis 
 After initial experiments with the Ste2p(1-71) peptide were unsuccessful, it was decided 
to ask CanPeptide Inc. to synthesize a shorter version of the Ste2p peptide for initial structural 
analysis.  Residues 14-43 from Ste2p were chosen to be synthesized because it encompassed a 
portion of the N-terminal end of Ste2p which has been previously shown to have helical 
structure (Neumoin et al., 2009), as well as residues Pro15, Ile24 and Ile29 where previous 
mutagenesis of these residues lead to significant loss in mating efficiency while maintaining 
wild-type levels of signalling (Shi et al., 2009a).  A shorter version of the peptide was also 
more cost-effective to produce and easier to synthesize.   
 CanPeptide Inc. was able to synthesize the Ste2p(14-43) peptide, however, when 
attempting to purify the synthesized peptide using HPLC, the peptide continually disappeared.  
These results were similar to what had happened with the Ste2p(2-54) peptide.  A 
hydrophobicity plot of the Ste2p(14-43) peptide demonstrated that portions of the C-terminal 
end of the peptide were hydrophobic (Figure 4.2).  This led us to believe that both of the 
peptides were too hydrophobic to be purified using the HPLC.  It has been previously shown 
that the addition of lysine residues to both termini of a peptide allowed for the production of a 
less hydrophobic peptide (Xie et al., 2000).  Despite its hydrophobic chain of four methylene 
groups, lysine has an amino group with a pI of ~10. Thus at pH’s less than 10 the amino group 
is ionized producing a very polar charged amino acid that can interact with aqueous solution 
yielding a much more soluble overall protein. At the same time In this previous study, after the 
addition of six lysine residues, the peptide was able to be purified using HPLC and used for 
structural analysis.  It was found that the addition of the lysine residues to both ends of the 
peptide had no significant effect on the helix formation of the residues in the peptide.  
However, more research needs to be done to explore the effect of the lysine residues on other 
domains.  Therefore, CanPeptide Inc. was asked to synthesize the KKK-Ste2p(14-43)-KKK 
peptide which would have three lysine residues before residue 14 and three lysine residues after 
residue 43.  After synthesizing the KKK-Ste2p(14-43)-KKK peptide CanPeptide Inc. was able 
to purify the peptide using HPLC.  Therefore, the addition of the lysine residues resulted in a 
less hydrophobic protein that could be purified, as predicted by the hydrophobicity plot of the 
KKK-Ste2p(14-43)-KKK peptide (Figure 4.3). 
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Figure 4.2: Hydrophobicity Plot of the Ste2p(14-43) Peptide. 
The hydrophobicity of the Ste2p(14-43) peptide was analyzed using ProtScale and based on the 
Kyte and Doolittle Hydropathicity model (Kyte and Doolittle, 1982).  Areas above 0 are 
considered to be hydrophobic and areas below 0 are considered to be hydrophilic. 
 
 
 
Figure 4.3: Hydrophobicity Plot of the KKK-Ste2p(14-43)-KKK Peptide. 
The hydrophobicity of the KKK-Ste2p(14-43)-KKK peptide was analyzed using ProtScale and 
based on the Kyte and Doolittle Hydropathicity model (Kyte and Doolittle, 1982).  Areas above 
0 are considered to be hydrophobic and areas below 0 are considered to be hydrophilic. 
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 Initial structural analysis was performed on the KKK-Ste2p(14-43)-KKK peptide in 
order to determine the solubility of the peptide in various solutions toward developing optimal 
conditions for NMR experiments.  Circular dichroism analysis of the KKK-Ste2p(14-43)-KKK 
peptide indicated secondary structure when dissolved in three different solvents, H2O, TFE/H2O 
and H2O with the detergent LPPG.  The peptide was also denatured at 60°C when in H2O and 
TFE and at 40°C when in H2O/LPPG.  The secondary structure was predicted to be ~ 42% β-
strand and 9% α-helix and ~46% β-strand and 9% α-helix, for H2O and LPPG, respectively,  
while the predicted secondary structure in the TFE sample was ~26% β-strand and 13% α-helix.  
These percentages are based on computational analysis and cannot be taken as accurate 
numbers.  Computational analysis is limited by the fact that structure content is estimated based 
on averaging given sets of control/known samples.  However, while the absolute values cannot 
be taken as accurate, relative changes between similar samples and between different conditions 
are meaningful for general comparisons.  The fact that there were higher amounts of α-helix in 
the TFE/H2O sample is not surprising due the fact that TFE is known to induce helical content 
(Sonnichsen et al., 1992).  Overall, the predicted amounts of ~42% β-strand and 9% α-helix 
were consistent with a previously predicted β-strand loop β-strand fold (Shi et al., 2009a) with 
the C-terminal residues (39-43) taking on an α-helical structure (Neumoin et al., 2009). As well 
the KKK-Ste2p(14-43)-KKK peptide contained a number of amino acids that have been shown 
to prefer β-strand conformation, such as Thr16, Tyr17, Gln21, Thr23, Ile24, Tyr26, Thr27, 
Ile29, Tyr30, Thr35, Ile36, Thr37, Phe38, and Gln 42 (Chou and Fasman, 1978). Therefore, it is 
not surprising that a large portion of the synthetic peptide was predicted to form β-strand.  
 Initial NMR analysis was performed on the KKK-Ste2p(14-43)-KKK peptide.  
Preliminary 2D –TOCSY and NOESY spectra were obtained from the sample and assignments 
of Phe and Tyr residues were able to be made from the TOCSY spectrum.  However, based on 
the size of the peptide, the number of crosspeaks that were observed in the spectra was quite a 
bit less than expected.  Therefore, a 2D- COSY spectrum was run on the sample in order to 
observe all of the backbone interactions.  The KKK-Ste2p(14-43)-KKK peptide contains 36 
amino acid residues which correlates to 37 expected crosspeaks in the 1HN-1Hα region of the 
2D-COSY spectrum.  The 2D-COSY spectrum was promising and displayed ~30 crosspeaks in 
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the 1HN-1Hα region.  Assignment of the proton spin systems of the six lysine and five threonine 
residues were made (Figure 3.16 and 3.17).  The observed proton shifts were similar to the 
predicted proton shifts for most of the protons (Table 3.2 and 3.3).  However, the predicted 
proton chemical shifts are obtained from NMR of very small peptides and real proton chemical 
shifts show a range of variations due to the sequence and structure of the peptide.  There was a 
larger chemical shift in the amide and alpha protons which may be due to their interactions with 
the protons of neighbouring amino acids.  Resonances arising from the side chains of all six 
lysines were virtually identical, in the spectrum indicting very little difference in their chemical 
environment within the peptide structure. This is expected based on their grouped arrangement 
of 3 consecutive lysines at each of the N and C-termini.  The ε-amino-protons were observed in 
the spectrum which is uncommon due to the rapid exchange of the protons when in water.  
However, it is very common for lysine amino residues to participate in a multitude of reactions 
which results in the amino residues being modified (Creighton, 1984). Therefore, most likely 
the amino protons have undergone a reaction which resulted in their modification.  The lack of 
clear separation for lysine backbone proton shifts and 1HN-1Hα crosspeaks is also likely at least 
in part representative of the similar chemical environment of each lysine.  The overlapped 1HN-
1Hα crosspeaks of the six lysines likely accounts for some (if not five) of the missing 1HN-1Hα 
crosspeaks. In contrast, the five threonines are dispersed throughout the peptide (Thr 16, Thr 
23, Thr 27, Thr 35 and Thr 37) and thus shift separation, particularly in the backbone region 
would be expected. While generally greater separation was observed for the lysine shifts 
compared to the threonine shifts, the resonances were still sufficiently overlapped that 
individual proton peaks could not be identified (Figure 3.18). Overlap of the five threonine 1HN-
1Hα crosspeaks could also account for some (if not 4) of the missing 1HN-1Hα crosspeaks. While 
this overlap may still be attributable to a similar chemical environment for the threonines, the 
problem is likely compounded by the generally broad nature of all the peaks in the spectrum, 
likely representing some degree of aggregation in the peptide sample.  In conclusion, some 
initial assignments were able to be made and more assignments are definitely possible.  
However, overall the lack of resolution arising from broad peaks in the 1H spectrum were an 
indication that the KKK-Ste2p(14-43)-KKK peptide was possibly aggregated, an issue that 
higher field magnets would not address.  The aggregation state of this peptide remains to be 
assessed by DLS.  
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4.3 SK Peptide Purification 
 After promising initial structural analyses of the KKK-Ste2p(14-43)-KKK peptide, the 
focus was shifted back to producing a recombinant N-terminal Ste2p peptide.  The major reason 
for this was to be able to label the protein with 15N by expressing the protein in isotopically 
enriched minimal medium.  Isotopic labelling of recombinant proteins is essential for structural 
elucidation using heteronuclear (15N-1H) NMR experiments.  The use of 15N-labelling results in 
the ability to observe specific nuclear interactions, such as the interactions between backbone 
nitrogens and interacting protons.  In addition, labelling the peptide with 15N allows for the 
sample to contain a lower concentration of peptide, such as 0.1-0.3 mM (Cohen et al., 2008; Su 
et al., 2008).  Working towards this goal a construct was produced that when expressed would 
contain residues 1-48 of Ste2p again with the KSI and His tags.  This construct was subjected to 
two rounds of mutagenesis to introduce three lysine residues between Met 1 and 2 of Ste2p(1-
48) and between 48 and Met49.  The construct was successfully expressed in E. coli and the 
resulting protein purified.  After cyanogen bromide cleavage of the fusion protein the expected 
peptide was the KKK-Ste2p(2-48)-KKK-M peptide.  Purification of this peptide using HPLC 
was successful and confirmed using MS.  Therefore, the addition of the lysine residues proved 
to decrease the hydrophobicity enough to allow for the peptide to be purified.  A 
hydrophobicity plot of the SK peptide (Figure 4.4) verified that the peptide is predicted to be 
less hydrophobic then the Ste2p(2-54) peptide (Figure 4.1).  However, using MS analysis it was 
shown that the peptide was not completely cleaved.  The resulting purified product was a 
combination of ~70% SK peptide as well as ~30% LM-SK peptide, which is the SK peptide 
with an additional Leucine and Methionine on the N-terminus.  Even though the SK peptide 
was not completely 100% pure it was decided to continue with structural analysis of the 
peptide.  The reasoning behind this is that the only difference between the two peptides is two 
amino acid residues.  Therefore, the majority of the nuclei from the amino acids will have 
identical chemical shifts in any obtained NMR spectra.  The only differences will be due to the 
nuclei from the L and M residues as well as the nuclei shifts of the N-terminal lysine residues 
of the LM-SK peptide may be affected, which could actually help assignment of N-terminal 
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versus C-terminal lysines.  However, since the abundance of LM-SK peptide is less than half of 
the SK peptide the resulting spectra will indicate which shifts are due to the LM-SK peptide 
and which are due to the SK peptide based on the magnitude of the peaks.  The final amount of 
peptide that was obtained was 11.5 mg from each initial litre of bacterial culture, which filled 
the requirement for the amount of pure protein needed for NMR.  Therefore, it was decided that 
structural analysis of the SK peptide could feasibly be attempted. 
 
 
 
 
 
Figure 4.4: Hydrophobicity Plot of the SK Peptide. 
The hydrophobicity of the SK peptide was analyzed using ProtScale and based on the Kyte and 
Doolittle Hydropathicity model (Kyte and Doolittle, 1982).  Areas above 0 are considered to be 
hydrophobic and areas below 0 are considered to be hydrophilic. 
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4.4 SK Peptide Structural Analysis 
 Previous broad peaks in the NMR spectra of the KKK-Ste2p(14-43)-KKK peptide had 
implied that the peptide was possibly aggregated.  Therefore, dynamic light scattering was 
performed on the SK peptide in order to determine the aggregation state of the peptide in a 
number of solutions.  The SK peptide displayed aggregation when dissolved in H2O or H2O 
with LPPG detergent.  However, it did not display aggregation when dissolved in TFE/H2O.  It 
is not unexpected that TFE/H2O would solubilise the peptide; it is a useful solution for 
dissolving proteins and has been very useful for structural analysis of hydrophobic peptides or 
proteins (Sonnichsen et al., 1992; Tyukhtenko et al., 2009).  Therefore, CD analysis was 
performed on the SK peptide in TFE/H2O.  The CD spectrum displayed secondary structure and 
was predicted to have ~52% β-strand and 6% α-helix.  When compared to the predicted 
secondary structure of KKK-Ste2p(14-43)-KKK in TFE/H2O which was ~ 26% β-strand and 
13% α-helix with an expected beta-turn, it indicates that a larger portion of the longer 
recombinant SK peptide is β-strand with relatively less α-helix.  It was shown previously that 
residues 39-47 of Ste2p form an α-helix (Neumoin et al., 2009), therefore, the higher β-strand 
content must be due to the structure of the N-terminal residues of the SK peptide. 
 NMR analysis of a 4 mM SK peptide sample in TFE/H2O/D2O resulted in a proton 
spectrum that contained many sharp peaks.  However, there were still fewer peaks than would 
be expected from a peptide with 54 amino acids.  In addition, there were a few very broad 
peaks especially in the 8 ppm region.  This spectrum indicated that the peptide was actually 
aggregated.  However, DLS analysis had shown that the peptide was not aggregated when 
dissolved in TFE/H2O.  The reason for this may be that the peptide concentration was too high.  
When the sample was analysed using DLS it was at a concentration of 0.2 mM where as the 
peptide concentration used during NMR was 4 mM.  Therefore, the increase in concentration 
may have resulted in aggregation of the peptide.  Another indication that the peptide was 
aggregated was that when the 2D-COSY was run on the 4 mM SK peptide sample it displayed 
very few crosspeaks in the 1HN-1Hα region, when there was expected to be 54 crosspeaks.  
Therefore, it would be better to decrease the concentration and confirm using DLS that the 
peptide is not aggregated before continuing with NMR analysis of the peptide.  NMR 
experiments have been previously run on isotopically labelled peptide samples of 3-7 kDa at 
concentrations of 0.2 - 1 mM and yielded good results (Nielsen et al., 1994; Seebahn et al., 
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2011).  So, if the SK peptide solubilised without aggregation at a lower concentration, there is a 
good chance the structure could be solved. 
 The SK peptide was also expressed, cleaved and purified after being isotopically 
labelled with 15N.  This was to allow 2D-heteronuclear (1H-15N) experiments to be performed 
on the peptide.  Confirmation of the presence of the 15N-SK peptide was attempted using MS 
after purifying the peptide using HPLC.  However, no peaks were found in the MS spectrum to 
indicate that the 15N-SK peptide was present in the sample.  There were a large number of 
peaks from 3000-4000 m.u. which indicated that possibly the 15N-SK peptide had degraded.  
However, a 2D 1H-15N HSQC was run on the sample at 3 mM to observe all 15N-labelled 
nitrogens and their attached protons.  Many 1H-15N interactions were observed on the 2D- 
HSQC spectrum indicating that the peptide had definitely been labelled with 15N.  However, 
since the peptide was degraded it was difficult to produce a clearly resolved spectrum.  The 
reason the peptide degraded is unknown but in future experiments MALDI-TOF-MS can be run 
on the sample after cyanogen bromide cleavage to ensure the peptide has not degraded prior to 
HPLC purification. 
 
 
 
4.5 Conclusions 
 In conclusion, a portion of the N-terminus of Ste2p was successfully expressed and 
purified from E. coli as a fusion protein, KSI-M-KKK-Ste2p(2-48)-KKK-M-HIS.  The fusion 
protein was cleaved after Met residues using cyanogen bromide cleavage in order to liberate the 
SK peptide.  The SK peptide was successfully purified using HPLC to mg quantities which 
were required for structural analysis.  Biophysical analysis of the SK peptide demonstrated that 
the peptide was not aggregated at lower concentrations and that there was secondary structure 
observed, which correlated with previous predictions.  NMR analysis on the SK peptide 
allowed for initial amino acid assignments but displayed very few crosspeaks from the 
backbone amino acids.  However, the successful isotopic labelling of the fusion protein with 
15N provides a possible avenue to elucidation of the structure of the N-terminus in the future. 
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4.6 Future Directions 
 Future experiments on this project would include trying to alleviate the aggregation 
problems of the SK peptide.  One solution would be to perform a screen of a number of 
different detergents in order to determine an optimal solution to dissolve the SK peptide.  This 
would require a detergent that solubilised the SK peptide at high concentrations while keeping 
the detergent concentration low so as not to interfere during NMR.  In addition, the detergent 
would have to be commercially available in a deuterated form for future NMR studies.  Also, 
experimenting with the solubilisation conditions could be helpful, such as increasing the 
temperature or using sonication.  Performing DLS on the peptide at the concentration intended 
to be used for NMR might be very helpful as well.  Another solvent system that could be used 
would be chloroform:methanol:water.  However, it is difficult to assess the aggregation state of 
the peptide using this solvent.  If however the SK peptide was unable to be solubilised then a 
synthetic 15N-labelled peptide could be produced and studied at lower concentrations.  In 
addition, if the aggregation problem is resolved, future NMR studies could be performed using 
higher power magnets to increase the resolution of the NMR spectra. 
 Future experiments that could be performed would be mutagenesis to produce N-
terminal fusion proteins containing I24A, I24C, I29A, I24C, P15C and then structural analysis 
to compare mutated SK peptide structures to wild type SK peptide structure.  This would give 
some insight into why the Ste2p receptor lost its mating efficiency after these residues were 
mutated.  Another interesting experiment that could be performed would be tandem affinity 
purification using the wild type or N-terminally truncated Ste3p and the SK peptide to 
determine if there is an interaction between the SK peptide and Ste3p.   
 
 
 
 
 
89 
 
5.0  REFERENCES 
 
Abu-Shumays, A., and Duffield, J.J. (1966). Circular dichroism theory and instrumentation. 
Anal Chem 38, A29-A58. 
Altenbach, C., Kusnetzow, A.K., Ernst, O.P., Hofmann, K.P., and Hubbell, W.L. (2008). High-
resolution distance mapping in rhodopsin reveals the pattern of helix movement due to 
activation. Proc Natl Acad Sci USA 105, 7439-7444. 
Arevalo, E., Estephan, R., Madeo, J., Arshava, B., Dumont, M., Becker, J.M., and Naider, F. 
(2003). Biosynthesis and biophysical analysis of domains of a yeast G protein-coupled receptor. 
Biopolymers 71, 516-531. 
Ash, J., Wu, C., Larocque, R., Jamal, M., Stevens, W., Osborne, M., Thomas, D.Y., and 
Whiteway, M. (2003). Genetic Analysis of the Interface Between Cdc42p and the CRIB 
Domain of Ste20p in Saccharomyces cerevisiae. Genetics 163, 9-20. 
Bardwell, L. (2005). A walk-through of the yeast mating pheromone response pathway. 
Peptides 26, 339-350. 
Berg, J.M., Tymoczko, J.L., and Stryer, L. (2002). Biochemistry, 5th edition (New York, W H 
Freeman). 
Bhasin, M., and Raghava, G.P.S. (2004). GPCRpred: an SVM-based method for prediction of 
families and subfamilies of G-protein coupled receptors. Nucl Acids Res 32, W383-389. 
Bockaert, J., and Pin, J.P. (1999). Molecular tinkering of G protein-coupled receptors: an 
evolutionary success. EMBO J 18, 1723-1729. 
Bohm, G., Muhr, R., and Jaenicke, R. (1992). Quantitative analysis of protein far UV circular 
dichroism spectra by neural networks. Protein Eng 5, 191-195. 
Bokoch, M.P., Zou, Y., Rasmussen, S.G.F., Liu, C.W., Nygaard, R., Rosenbaum, D.M., Fung, 
J.J., Choi, H.-J., Thian, F.S., Kobilka, T.S., et al. (2010). Ligand-specific regulation of the 
extracellular surface of a G-protein-coupled receptor. Nature 463, 108-112. 
Boxer, D.H., Zhang, H., Gourley, D.G., Hunter, W.N., Kelly, S.M., and Price, N.C. (2004). 
Sensing of remote oxyanion binding at the DNA binding domain of the molybdate-dependent 
transcriptional regulator, ModE. Org Biomol Chem 2, 2829-2837. 
Brahms, S., and Brahms, J. (1980). Determination of protein secondary structure in solution by 
vacuum ultraviolet circular dichroism. J Mol Biol 138, 149-178. 
Bulenger, S., Marullo, S., and Bouvier, M. (2005). Emerging role of homo- and 
heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends 
Pharmacol Sci 26, 131-137. 
90 
 
Butty, A.-C., Pryciak, P.M., Huang, L.S., Herskowitz, I., and Peter, M. (1998). The Role of 
Far1p in Linking the Heterotrimeric G Protein to Polarity Establishment Proteins During Yeast 
Mating. Science 282, 1511-1516. 
Cardoso, J., Pinto, V., Vieira, F., Clark, M., and Power, D. (2006). Evolution of secretin family 
GPCR members in the metazoa. BMC Evol Biol 6, 108. 
Cavanagh, J., Fairbrother, W.J., III, A.G.P., and Skeleton, N.J. (1996). Protein NMR 
spectroscopy: principles and practice (San Diego, CA, Academic Press). 
Chen, E.H., Grote, E., Mohler, W., and Vignery, A. (2007). Cell-cell fusion. FEBS Letters 581, 
2181-2193. 
Cheng, B.Y.M., Carbonell, J.G., and Klein-Seetharaman, J. (2005). Protein classification based 
on text document classification techniques. Proteins: Struct, Funct, Bioinf 58, 955-970. 
Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G.F., Thian, F.S., Kobilka, T.S., 
Choi, H.-J., Kuhn, P., Weis, W.I., Kobilka, B.K., et al. (2007). High-Resolution Crystal 
Structure of an Engineered Human β2-Adrenergic G Protein Coupled Receptor. Science 318, 
1258-1265. 
Chien, E.Y.T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M.A., Shi, L., Newman, 
A.H., Javitch, J.A., Cherezov, V., et al. (2010). Structure of the Human Dopamine D3 Receptor 
in Complex with a D2/D3 Selective Antagonist. Science 330, 1091-1095. 
Chou, K.C., and Elrod, D.W. (2002). Bioinformatical Analysis of G-Protein-Coupled 
Receptors. J Proteome Res 1, 429-433. 
Chou, P.Y., and Fasman, G.D. (1978). Empirical Predictions of Protein Conformation. Annu 
Rev Biochem 47, 251-276. 
Chung, D.A., Zuiderweg, E.R.P., Fowler, C.B., Soyer, O.S., Mosberg, H.I., and Neubig, R.R. 
(2002). NMR Structure of the Second Intracellular Loop of the α2A Adrenergic Receptor: 
Evidence for a Novel Cytoplasmic Helix. Biochemistry 41, 3596-3604. 
Cohen, L.S., Arshava, B., Estephan, R., Englander, J., Kim, H., Hauser, M., Zerbe, O., Ceruso, 
M., Becker, J.M., and Naider, F. (2008). Expression and biophysical analysis of two double-
transmembrane domain-containing fragments from a yeast G protein-coupled receptor. Peptide 
Sci 90, 117-130. 
Conner, M., Hicks, M.R., Dafforn, T., Knowles, T.J., Ludwig, C., Staddon, S., Overduin, M., 
Gunther, U.L., Thome, J., Wheatley, M., et al. (2008). Functional and Biophysical Analysis of 
the C-Terminus of the CGRP-Receptor; a Family B GPCR. Biochemistry 47, 8434-8444. 
Cook, G., Stefer, S., and Opella, S.J. (2010). Expression and purification of the membrane 
protein p7 from HCV. Biopolymers 96, 32-40. 
91 
 
Creighton, T.E. (1984). Proteins: Structures and Molecular Properties (New York, NY, W.H 
Freeman and Company). 
Dohlman, H.G. (2002). G Proteins and Pheromone Signaling. Annu Rev Physiol 64, 129-152. 
Dohlman, H.G., Thorner, J., Caron, M.G., and Lefkowitz, R.J. (1991). Model Systems for the 
Study of Seven-Transmembrane-Segment Receptors. Annu Rev Biochem 60, 653-688. 
Eilers, M., Hornak, V., Smith, S.O., and Konopka, J.B. (2005). Comparison of Class A and D G 
Protein-Coupled Receptors: Common Features in Structure and Activation. Biochemistry 44, 
8959-8975. 
Elion, E.A. (2000). Pheromone response, mating and cell biology. Curr Opin Microbiol 3, 573-
581. 
Engelman, D.M., Steitz, T.A., and Goldman, A. (1986). Identifying Nonpolar Transbilayer 
Helices in Amino Acid Sequences of Membrane Proteins. Annu Rev Biophys Biophys Chem 
15, 321-353. 
Estephan, R., Englander, J., Arshava, B., Samples, K.L., Becker, J.M., and Naider, F. (2005). 
Biosynthesis and NMR Analysis of a 73-Residue Domain of a Saccharomyces cerevisiae G 
Protein-Coupled Receptor. Biochemistry 44, 11795-11810. 
Fredriksson, R., Lagerström, M.C., Lundin, L.G., and Schiöth, H.B. (2003). The G-Protein-
Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, 
Paralogon Groups, and Fingerprints. Mol Pharmacol 63, 1256-1272. 
Freedman, S.J., Furie, B.C., Furie, B., and Baleja, J.D. (1995). Structure of the Metal-free γ-
Carboxyglutamic Acid-rich Membrane Binding Region of Factor IX by Two-dimensional 
NMR Spectroscopy. J Biol Chem 270, 7980-7987. 
Gardner, K.H., and Kay, L.E. (1998). The use of 2H, 13C, 15N multidimensional NMR to study 
the structure and dynamics of proteins. Annu Rev Biophys Biomol Struct 27, 357-406. 
Gautier, A., Mott, H.R., Bostock, M.J., Kirkpatrick, J.P., and Nietlispach, D. (2010). Structure 
determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution 
NMR spectroscopy. Nat Struct Mol Biol 17, 768-774. 
Gehret, A.U., Bajaj, A., Naider, F., and Dumont, M.E. (2006). Oligomerization of the Yeast α-
Factor Receptor. J Biol Chem 281, 20698-20714. 
Goto, N.K., and Kay, L.E. (2000). New developments in isotope labeling strategies for protein 
solution NMR spectroscopy. Curr Opin Struct Biol 10, 585-592. 
Gross, E., and Witkop, B. (1962). Nonenzymatic Cleavage of Peptide Bonds: The Methionine 
Residues in Bovine Pancreatic Ribonuclease. J Biol Chem 237, 1856-1860. 
92 
 
Hanson, M.A., Cherezov, V., Griffith, M.T., Roth, C.B., Jaakola, V.P., Chien, E.Y., Velasquez, 
J., Kuhn, P., and Stevens, R.C. (2008). A Specific Cholesterol Binding Site Is Established by 
the 2.8 Å Structure of the Human β2-Adrenergic Receptor. Structure 16, 897-905. 
He, L., Fong, J., von Zastrow, M., and Whistler, J.L. (2002). Regulation of Opioid Receptor 
Trafficking and Morphine Tolerance by Receptor Oligomerization. Cell 108, 271-282. 
Hennessey, J.P., and Johnson, W.C. (1981). Information content in the circular dichroism of 
proteins. Biochemistry 20, 1085-1094. 
Herskowitz, I. (1995). MAP kinase pathways in yeast: For mating and more. Cell 80, 187-197. 
Horn, F., Bettler, E., Oliveira, L., Campagne, F., Cohen, F.E., and Vriend, G. (2003). GPCRDB 
information system for G protein-coupled receptors. Nucl Acids Res 31, 294-297. 
Iannone, M. (1999). Exploring Fourier Transform Techniques with Mathcad. J Chem Educ 76, 
286. 
Inoue, H., Nojima, H., and Okayama, H. (1990). High efficiency transformation of Escherichia 
coli with plasmids. Gene 96, 23-28. 
Jaakola, V.-P., Griffith, M.T., Hanson, M.A., Cherezov, V., Chien, E.Y.T., Lane, J.R., 
IJzerman, A.P., and Stevens, R.C. (2008). The 2.6 Angstrom Crystal Structure of a Human A2A 
Adenosine Receptor Bound to an Antagonist. Science 322, 1211-1217. 
Jacoby, E., Bouhelal, R., Gerspacher, M., and Seuwen, K. (2006). The 7 TM G-Protein-
Coupled Receptor Target Family13. Chem Med Chem 1, 760-782. 
Jordan, B.A., and Devi, L.A. (1999). G-protein-coupled receptor heterodimerization modulates 
receptor function. Nature 399, 697-700. 
Kelly, S.M., Jess, T.J., and Price, N.C. (2005). How to study proteins by circular dichroism. 
Biochim Biophys Acta 1751, 119-139. 
Kelly, S.M., and Price, N.C. (1997). The application of circular dichroism to studies of protein 
folding and unfolding. Biochim Biophys Acta 1338, 161-185. 
Kolakowski Jr., L.F. (1994). GCRDb: A G-Protein-Coupled Receptor Database. Receptor 
Channel 2, 1-7. 
Konopka, J.B., and Fields, S. (1992). The pheromone signal pathway in Saccharomyces 
cerevisiae. Antonie Van Leeuwenhoek 62, 95-108. 
Konopka, J.B., Margarit, S.M., and Dube, P. (1996). Mutation of Pro-258 in transmembrane 
domain 6 constitutively activates the G protein-coupled alpha-factor receptor. Proc Natl Acad 
Sci USA 93, 6764-6769. 
93 
 
Kristiansen, K. (2004). Molecular mechanisms of ligand binding, signaling, and regulation 
within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis 
approaches to receptor structure and function. Pharmacol Therapeut 103, 21-80. 
Krueger-Koplin, R.D., Sorgen, P.L., Krueger-Koplin, S.T., Rivera-Torres, I.O., Cahill, S.M., 
Hicks, D.B., Grinius, L., Krulwich, T.A., and Girvin, M.E. (2004). An evaluation of detergents 
for NMR structural studies of membrane proteins. J Biomol NMR 28, 43-57. 
Kuliopulos, A., Shortle, D., and Talalay, P. (1987). Isolation and sequencing of the gene 
encoding delta 5-3-ketosteroid isomerase of Pseudomonas testosteroni: overexpression of the 
protein. Proc Nat Acad Sci USA 84, 8893-8897. 
Kuliopulos, A., and Walsh, C.T. (1994). Production, Purification, and Cleavage of Tandem 
Repeats of Recombinant Peptides. J Am Chem Soc 116, 4599-4607. 
Kyte, J., and Doolittle, R.F. (1982). A simple method for displaying the hydropathic character 
of a protein. J Mol Biol 157, 105-132. 
Lambright, D.G., Noel, J.P., Hamm, H.E., and Sigler, P.B. (1994). Structural determinants for 
activation of the α-subunit of a heterotrimeric G protein. Nature 369, 621-628. 
Li, J., Edwards, P.C., Burghammer, M., Villa, C., and Schertler, G.F.X. (2004a). Structure of 
Bovine Rhodopsin in a Trigonal Crystal Form. J Mol Biol 343, 1409-1438. 
Li, S., Xing, D., and Li, J. (2004b). Dynamic Light Scattering Application to Study Protein 
Interactions in Electrolyte Solutions. J Biol Phys 30, 313-324. 
Lim, L., Manser, E., Leung, T., and Hall, C. (1996). Regulation of phosphorylation pathways 
by p21 GTPases. Eur J Biochem 242, 171-185. 
Madden, K., and Snyder, M. (1998). Cell Polarity and Morphogenesis in Budding Yeast. Annu 
Rev Microbiol 52, 687-744. 
Marsh, L., Neiman, A.M., and Herskowitz, I. (1991). Signal Transduction During Pheromone 
Response in Yeast. Annu Rev Cell Biol 7, 699-728. 
Marshall, F.H., Jones, K.A., Kaupmann, K., and Bettler, B. (1999). GABAB receptors - the first 
7TM heterodimers. Trends Pharmacol Sci 20, 396-399. 
Milligan, G. (2004). G Protein-Coupled Receptor Dimerization: Function and Ligand 
Pharmacology. Mol Pharmacol 66, 1-7. 
Milligan, G. (2009). G protein-coupled receptor hetero-dimerization: contribution to 
pharmacology and function. Br J Pharmacol 158, 5-14. 
Mittermaier, A., and Kay, L.E. (2006). New Tools Provide New Insights in NMR Studies of 
Protein Dynamics. Science 312, 224-228. 
94 
 
Monera, O.D., Sereda, T.J., Zhou, N.E., Kay, C.M., and Hodges, R.S. (1995). Relationship of 
sidechain hydrophobicity and α-helical propensity on the stability of the single-stranded 
amphipathic α-helix. J Peptide Sci 1, 319-329. 
Murphy, R.M., and Tsai, A.M. (2006). Misbehaving Proteins: Protein (Mis)Folding, 
Aggregation, and Stability (New York, NY, Springer).  
Naider, F., Arshava, B., Ding, F.X., Arevalo, E., and Becker, J.M. (2001). Peptide fragments as 
models to study the structure of a G-protein coupled receptor: The α-factor receptor of 
Saccharomyces cerevisiae. Biopolymers 60, 334-350. 
Nelson, G., Hoon, M.A., Chandrashekar, J., Zhang, Y., Ryba, N.J.P., and Zuker, C.S. (2001). 
Mammalian Sweet Taste Receptors. Cell 106, 381-390. 
Neumoin, A., Arshava, B., Becker, J., Zerbe, O., and Naider, F. (2007). NMR Studies in 
Dodecylphosphocholine of a Fragment Containing the Seventh Transmembrane Helix of a G-
Protein-Coupled Receptor from Saccharomyces cerevisiae. Biophys J 93, 467-482. 
Neumoin, A., Cohen, L.S., Arshava, B., Tantry, S., Becker, J.M., Zerbe, O., and Naider, F. 
(2009). Structure of a Double Transmembrane Fragment of a G-Protein-Coupled Receptor in 
Micelles. Biophys J 96, 3187-3196. 
Nielsen, K.J., Heath, R.L., Anderson, M.A., and Craik, D.J. (1994). The Three-dimensional 
Solution Structure by 1H NMR of a 6-Kda Proteinase Inhibitor Isolated from the Stigma of 
Nicotiana alata. J Mol Biol 242, 231-243. 
Nobbmann, U., Connah, M., Fish, B., Varley, P., Gee, C., Mulot, S., Chen, J., Zhou, L., Lu, Y., 
Sheng, F., et al. (2007). Dynamic light scattering as a relative tool for assessing the molecular 
integrity and stability of monoclonal antibodies. Biotechnol Genet Eng Rev 24, 117-128. 
Oakley, M.T., Bulheller, B.M., and Hirst, J.D. (2006). First-principles calculations of protein 
circular dichroism in the far-ultraviolet and beyond. Chirality 18, 340-347. 
Okada, T., Fujiyoshi, Y., Silow, M., Navarro, J., Landau, E.M., and Shichida, Y. (2002). 
Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography. 
Proc Natl Acad Sci USA 99, 5982-5987. 
Okada, T., Sugihara, M., Bondar, A.-N., Elstner, M., Entel, P., and Buss, V. (2004). The 
Retinal Conformation and its Environment in Rhodopsin in Light of a New 2.2 A Crystal 
Structure. J Mol Biol 342, 571-583. 
Overton, M.C., Chinault, S.L., and Blumer, K.J. (2003). Oligomerization, Biogenesis, and 
Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 
1 of a Yeast G Protein-coupled Receptor. J Biol Chem 278, 49369-49377. 
Overton, M.C., Chinault, S.L., and Blumer, K.J. (2005). Oligomerization of G-Protein-Coupled 
Receptors: Lessons from the Yeast Saccharomyces cerevisiae. Eukaryotic Cell 4, 1963-1970. 
95 
 
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Trong, I.L., 
Teller, D.C., Okada, T., Stenkamp, R.E., et al. (2000). Crystal Structure of Rhodopsin: A G 
Protein-Coupled Receptor. Science 289, 739-745. 
Pervushin, K., Riek, R., Wider, G., and Wüthrich, K. (1997). Attenuated T2 relaxation by 
mutual cancellation of dipole–dipole coupling and chemical shift anisotropy indicates an 
avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad 
Sci USA 94, 12366-12371. 
Pierce, K.L., Premont, R.T., and Lefkowitz, R.J. (2002). Seven-transmembrane receptors. Nat 
Rev Mol Cell Biol 3, 639-650. 
Pin, J.-P., Galvez, T., and Prézeau, L. (2003). Evolution, structure, and activation mechanism of 
family 3/C G-protein-coupled receptors. Pharmacol Ther 98, 325-354. 
Probst, W.C., Snyder, L.A., Schuster, D.I., Brosius, J., and Sealfon, S.C. (1992). Sequence 
alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11, 1-20. 
Pryciak, P.M., and Huntress, F.A. (1998). Membrane recruitment of the kinase cascade scaffold 
protein Ste5 by the Gβγ complex underlies activation of the yeast pheromone response 
pathway. Genes Dev 12, 2684-2697. 
Raicu, V., Jansma, D.B., Miller, R.J.D., and Friesen, J.D. (2005). Protein interaction quantified 
in vivo by spectrally resolved fluorescence resonance energy transfer. Biochem J 385, 265-277. 
Raisley, B., Zhang, M., Hereld, D., and Hadwiger, J.A. (2004). A cAMP receptor-like G 
protein-coupled receptor with roles in growth regulation and development. Dev Biol 265, 433-
445. 
Rasmussen, S.G.F., Choi, H.-J., Rosenbaum, D.M., Kobilka, T.S., Thian, F.S., Edwards, P.C., 
Burghammer, M., Ratnala, V.R.P., Sanishvili, R., Fischetti, R.F., et al. (2007). Crystal structure 
of the human β2 adrenergic G-protein-coupled receptor. Nature 450, 383-387. 
Ravindran, A., Joseph, P.R.B., and Rajarathnam, K. (2009). Structural Basis for Differential 
Binding of the Interleukin-8 Monomer and Dimer to the CXCR1 N-Domain: Role of Coupled 
Interactions and Dynamics. Biochemistry 48, 8795-8805. 
Roberts, G.C.K., ed. (1993). NMR of macromolecules: a practical approach (New York, NY, 
Oxford University Press). 
Rodríguez, J.C., Wong, L., and Jennings, P.A. (2003). The solvent in CNBr cleavage reactions 
determines the fragmentation efficiency of ketosteroid isomerase fusion proteins used in the 
production of recombinant peptides. Protein Express Purif 28, 224-231. 
Rosenbaum, D.M., Cherezov, V., Hanson, M.A., Rasmussen, S.G.F., Thian, F.S., Kobilka, T.S., 
Choi, H.-J., Yao, X.-J., Weis, W.I., Stevens, R.C., et al. (2007). GPCR Engineering Yields 
High-Resolution Structural Insights into β2-Adrenergic Receptor Function. Science 318, 1266-
1273. 
96 
 
Rosenberg, A.H., Lade, B.N., Dao-shan, C., Lin, S.-W., Dunn, J.J., and Studier, F.W. (1987). 
Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56, 125-135. 
Sajedi, R., Naderi-Manesh, H., Khajeh, K., Ranjbar, B., Ghaemi, N., and Naderi-Manesh, M. 
(2004). Purification, characterization, and structural investigation of a new moderately 
thermophilic and partially calcium-independent extracellular α-amylase from Bacillus sp. TM1. 
App Biochem Biotechnol 119, 41-50. 
Sajedi, R.H., Taghdir, M., Naderi-Manesh, H., Khajeh, K., and Ranjbar, B. (2007). Nucleotide 
sequence, structural investigation and homology modeling studies of a Ca2+ independant α-
amylase with acidic pH-profile. J Biochem Mol Biol 40, 315-324. 
Salahpour, A., Angers, S., Mercier, J.-F., Lagacé, M., Marullo, S., and Bouvier, M. (2004). 
Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting. 
J Biol Chem 279, 33390-33397. 
Salom, D., Lodowski, D.T., Stenkamp, R.E., Trong, I.L., Golczak, M., Jastrzebska, B., Harris, 
T., Ballesteros, J.A., and Palczewski, K. (2006). Crystal structure of a photoactivated 
deprotonated intermediate of rhodopsin. P Natl Acad Sci USA 103, 16123-16128. 
Sanders, C.R., and Landis, G.C. (1995). Reconstitution of Membrane Proteins into Lipid-Rich 
Bilayered Mixed Micelles for NMR Studies. Biochemistry 34, 4030-4040. 
Scheerer, P., Park, J.H., Hildebrand, P.W., Kim, Y.J., Krausz, N., Choe, H.-W., Hofmann, K.P., 
and Ernst, O.P. (2008). Crystal structure of opsin in its G-protein-interacting conformation. 
Nature 455, 497-502. 
Schulte, G., and Bryja, V. (2007). The Frizzled family of unconventional G-protein-coupled 
receptors. Trends Pharmacol Sci 28, 518-525. 
Seebahn, A., Dinkel, H., Mohrlüder, J., Hartmann, R., Vogel, N., Becker, C.-M., Sticht, H., and 
Enz, R. (2011). Structural characterization of intracellular C-terminal domains of group III 
metabotropic glutamate receptors. FEBS Letters 585, 511-516. 
Shi, C., Kaminskyj, S., Caldwell, S., and Loewen, M.C. (2007). A role for a complex between 
activated G protein-coupled receptors in yeast cellular mating. Proc Natl Acad Sci USA 104, 
5395-5400. 
Shi, C., Kendall, S.C., Grote, E., Kaminskyj, S., and Loewen, M.C. (2009a). N-terminal 
residues of the yeast pheromone receptor, Ste2p, mediate mating events independently of G1-
arrest signaling. J Cell Biochem 107, 630-638. 
Shi, C., Paige, M.F., Maley, J., and Loewen, M.C. (2009b). In vitro characterization of ligand-
induced oligomerization of the S. cerevisiae G-protein coupled receptor, Ste2p. Biochim 
Biophys Acta-Gen Subjects 1790, 1-7. 
Silverstein, R.M., Webster, F.X., and Kiemle, D., eds. (2005). Spectrometric identification of 
organic compounds, 7th edn (Hoboken, NJ, John Wiley & Sons, Inc.). 
97 
 
Sommers, C.M., Martin, N.P., Akal-Strader, A., Becker, J.M., Naider, F., and Dumont, M.E. 
(2000). A Limited Spectrum of Mutations Causes Constitutive Activation of the Yeast α-Factor 
Receptor. Biochemistry 39, 6898-6909. 
Sonnichsen, F.D., Van Eyk, J.E., Hodges, R.S., and Sykes, B.D. (1992). Effect of 
trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin 
peptide. Biochemistry 31, 8790-8798. 
Stark, J., and Powers, R. (2007). Rapid Protein−Ligand Costructures Using Chemical Shift 
Perturbations. J Am Chem Soc 130, 535-545. 
Studier, F.W., and Moffatt, B.A. (1986). Use of bacteriophage T7 RNA polymerase to direct 
selective high-level expression of cloned genes. J Mol Biol 189, 113-130. 
Su, Z., Sukdeo, N., and Honek, J.F. (2008). 15N−1H HSQC NMR Evidence for Distinct 
Specificity of Two Active Sites in Escherichia coli Glyoxalase I. Biochemistry 47, 13232-
13241. 
Tapaneeyakorn, S., Goddard, A.D., Oates, J., Willis, C.L., and Watts, A. (2011). Solution- and 
solid-state NMR studies of GPCRs and their ligands. Biochim Biophys Acta-Biomembranes 
1808, 1462-1475. 
Teller, D.C., Okada, T., Behnke, C.A., Palczewski, K., and Stenkamp, R.E. (2001). Advances 
in Determination of a High-Resolution Three-Dimensional Structure of Rhodopsin, a Model of 
G-Protein-Coupled Receptors (GPCRs). Biochemistry 40, 7761-7772. 
Terrillon, S., and Bouvier, M. (2004). Roles of G-protein-coupled receptor dimerization. 
EMBO Rep 5, 30-34. 
Tyukhtenko, S., Tiburu, E.K., Deshmukh, L., Vinogradova, O., Janero, D.R., and Makriyannis, 
A. (2009). NMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: 
Candidate electrostatic interactions and microdomain formation. Biochem Biophys Res 
Commun 390, 441-446. 
Ulfers, A.L., Piserchio, A., and Mierke, D.F. (2002). Extracellular domains of the neurokinin-1 
receptor: Structural characterization and interactions with substance P. Peptide Sci 66, 339-349. 
Wand, A.J. (2001). Dynamic activation of protein function: A view emerging from NMR 
spectroscopy. Nat Struct Biol 8, 926-931. 
Wang, Y., and Dohlman, H.G. (2004). Pheromone Signaling Mechanisms in Yeast: A 
Prototypical Sex Machine. Science 306, 1508-1509. 
Wang, Y., Zhou, Z., Walsh, C.T., and McMahon, A.P. (2009). Selective translocation of 
intracellular Smoothened to the primary cilium in response to Hedgehog pathway modulation. 
Proc Natl Acad Sci USA 106, 2623-2628. 
98 
 
Warne, T., Serrano-Vega, M.J., Baker, J.G., Moukhametzianov, R., Edwards, P.C., Henderson, 
R., Leslie, A.G.W., Tate, C.G., and Schertler, G.F.X. (2008). Structure of a β1-adrenergic G-
protein-coupled receptor. Nature 454, 486-491. 
Werner, K., Richter, C., Klein-Seetharaman, J., and Schwalbe, H. (2008). Isotope labeling of 
mammalian GPCRs in HEK293 cells and characterization of the C-terminus of bovine 
rhodopsin by high resolution liquid NMR spectroscopy. J Biomol NMR 40, 49-53. 
Wu, B., Chien, E.Y.T., Mol, C.D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., 
Wells, P., Bi, F.C., et al. (2010). Structures of the CXCR4 Chemokine GPCR with Small-
Molecule and Cyclic Peptide Antagonists. Science 330, 1066-1071. 
Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids (Hoboken, NJ, John Wiley & Sons). 
Xie, H., Ding, F.-X., Schreiber, D., Eng, G., Liu, S.-f., Arshava, B., Arevalo, E., Becker, J.M., 
and Naider, F. (2000). Synthesis and Biophysical Analysis of Transmembrane Domains of a 
Saccharomyces cerevisiae G Protein-Coupled Receptor. Biochemistry 39, 15462-15474. 
Zheng, H., Zhao, J., Sheng, W., and Xie, X.-Q. (2006). A transmembrane helix-bundle from G-
protein coupled receptor CB2: Biosynthesis, purification, and NMR characterization. 
Biopolymers 83, 46-61. 
Zou, C., Naider, F., and Zerbe, O. (2008). Biosynthesis and NMR-studies of a double 
transmembrane domain from the Y4 receptor, a human GPCR. J Biomol NMR 42, 257-269. 
 
 
 
